key: cord-0018006-cwgwem7o
authors: Shi, Chunhu; Dumville, Jo C; Cullum, Nicky; Rhodes, Sarah; McInnes, Elizabeth
title: Alternative reactive support surfaces (non‐foam and non‐air‐filled) for preventing pressure ulcers
date: 2021-05-06
journal: Cochrane Database Syst Rev
DOI: 10.1002/14651858.cd013623.pub2
sha: 7085dc305d7df8cd155e1f90717876b4c5ac8f06
doc_id: 18006
cord_uid: cwgwem7o

BACKGROUND: Pressure ulcers (also known as injuries, pressure sores, decubitus ulcers and bed sores) are localised injuries to the skin or underlying soft tissue, or both, caused by unrelieved pressure, shear or friction. Reactive surfaces that are not made of foam or air cells can be used for preventing pressure ulcers. OBJECTIVES: To assess the effects of non‐foam and non‐air‐filled reactive beds, mattresses or overlays compared with any other support surface on the incidence of pressure ulcers in any population in any setting. SEARCH METHODS: In November 2019, we searched the Cochrane Wounds Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE (including In‐Process & Other Non‐Indexed Citations); Ovid Embase and EBSCO CINAHL Plus. We also searched clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies as well as reviews, meta‐analyses and health technology reports to identify additional studies. There were no restrictions with respect to language, date of publication or study setting. SELECTION CRITERIA: We included randomised controlled trials that allocated participants of any age to non‐foam or non‐air‐filled reactive beds, overlays or mattresses. Comparators were any beds, overlays or mattresses used. DATA COLLECTION AND ANALYSIS: At least two review authors independently assessed studies using predetermined inclusion criteria. We carried out data extraction, 'Risk of bias' assessment using the Cochrane 'Risk of bias' tool, and the certainty of the evidence assessment according to Grading of Recommendations, Assessment, Development and Evaluations methodology. If a non‐foam or non‐air‐filled surface was compared with surfaces that were not clearly specified, then the included study was recorded and described but not considered further in any data analyses. MAIN RESULTS: We included 20 studies (4653 participants) in this review. Most studies were small (median study sample size: 198 participants). The average participant age ranged from 37.2 to 85.4 years (median: 72.5 years). Participants were recruited from a wide range of care settings but were mainly from acute care settings. Almost all studies were conducted in Europe and America. Of the 20 studies, 11 (2826 participants) included surfaces that were not well described and therefore could not be fully classified. We synthesised data for the following 12 comparisons: (1) reactive water surfaces versus alternating pressure (active) air surfaces (three studies with 414 participants), (2) reactive water surfaces versus foam surfaces (one study with 117 participants), (3) reactive water surfaces versus reactive air surfaces (one study with 37 participants), (4) reactive water surfaces versus reactive fibre surfaces (one study with 87 participants), (5) reactive fibre surfaces versus alternating pressure (active) air surfaces (four studies with 384 participants), (6) reactive fibre surfaces versus foam surfaces (two studies with 228 participants), (7) reactive gel surfaces on operating tables followed by foam surfaces on ward beds versus alternating pressure (active) air surfaces on operating tables and subsequently on ward beds (two studies with 415 participants), (8) reactive gel surfaces versus reactive air surfaces (one study with 74 participants), (9) reactive gel surfaces versus foam surfaces (one study with 135 participants), (10) reactive gel surfaces versus reactive gel surfaces (one study with 113 participants), (11) reactive foam and gel surfaces versus reactive gel surfaces (one study with 166 participants) and (12) reactive foam and gel surfaces versus foam surfaces (one study with 91 participants). Of the 20 studies, 16 (80%) presented findings which were considered to be at high overall risk of bias. Primary outcome: Pressure ulcer incidence We did not find analysable data for two comparisons: reactive water surfaces versus foam surfaces, and reactive water surfaces versus reactive fibre surfaces. Reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds (14/205 (6.8%)) may increase the proportion of people developing a new pressure ulcer compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds (3/210 (1.4%) (risk ratio 4.53, 95% confidence interval 1.31 to 15.65; 2 studies, 415 participants; I(2) = 0%; low‐certainty evidence). For all other comparisons, it is uncertain whether there is a difference in the proportion of participants developing new pressure ulcers as all data were of very low certainty. Included studies did not report time to pressure ulcer incidence for any comparison in this review. Secondary outcomes Support‐surface‐associated patient comfort: the included studies provide data on this outcome for one comparison. It is uncertain if there is a difference in patient comfort between alternating pressure (active) air surfaces and reactive fibre surfaces (one study with 187 participants; very low‐certainty evidence). All reported adverse events: there is evidence on this outcome for one comparison. It is uncertain if there is a difference in adverse events between reactive gel surfaces followed by foam surfaces and alternating pressure (active) air surfaces applied on both operating tables and hospital beds (one study with 198 participants; very low‐certainty evidence). We did not find any health‐related quality of life or cost‐effectiveness evidence for any comparison in this review. AUTHORS' CONCLUSIONS: Current evidence is generally uncertain about the differences between non‐foam and non‐air‐filled reactive surfaces and other surfaces in terms of pressure ulcer incidence, patient comfort, adverse effects, health‐related quality of life and cost‐effectiveness. Reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds may increase the risk of having new pressure ulcers compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds. Future research in this area should consider evaluation of the most important support surfaces from the perspective of decision‐makers. Time‐to‐event outcomes, careful assessment of adverse events and trial‐level cost‐effectiveness evaluation should be considered in future studies. Trials should be designed to minimise the risk of detection bias; for example, by using digital photography and adjudicators of the photographs being blinded to group allocation. Further review using network meta‐analysis will add to the findings reported here.

It is uncertain if there is any difference between reactive water surfaces and alternating pressure (active) air surfaces in the proportion of participants developing a new pressure ulcer.

Time to pressure ulcer incidence Included studies did not report this outcome.

Included studies did not report this outcome.

All reported adverse events Included studies did not report this outcome. It is uncertain whether there is a difference in the proportion of participants developing a new pressure ulcer between reactive fibre surfaces and alternating pressure (active) air surfaces.

Time to pressure ulcer incidence

The included studies did not report this outcome. It is uncertain if there is a difference in the proportion of participants developing a new pressure ulcer between reactive fibre surfaces and foam surfaces.

Time to pressure ulcer incidence The included study did not report this outcome.

Support surface-associated patient comfort

The included study did not report this outcome.

All reported adverse events The included study did not report this outcome.

Health-related quality of life The included study did not report this outcome.

The included study did not report this outcome.

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

GRADE Working Group grades of evidence High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

a Downgraded twice for unclear risk of bias in all domains. b Downgraded twice for imprecision as the OIS was not met and the wide confidence interval crossed RRs = 0.75 and 1.25. Reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds may increase the proportion of people developing a new pressure ulcer compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds.

Time to pressure ulcer incidence

The included studies did not report this outcome.

The included studies did not report this outcome.

All reported adverse events Follow-up: 7 days Russell 2000 (198 participants) reported that approximately ½ of people in each group reported adverse events, with no difference between groups reported. No adverse events were related to the mattresses assigned. It is uncertain if there is a difference in the proportion of participants developing a new ulcer between reactive gel surfaces and reactive air surfaces.

Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews

Pressure ulcers -also known as pressure injuries, pressure sores, decubitus ulcers and bed sores -are localised injuries to the skin or underlying so tissue (or both) caused by unrelieved pressure, shear or friction (NPIAP 2016) . Pressure ulcer severity is generally classified using the National Pressure Injury Advisory Panel (NPIAP) system (NPIAP 2016).

• Stage 1: intact skin with a local appearance of non-blanchable erythema • Stage 2: partial-thickness skin loss with exposed dermis • Stage 3: full-thickness skin loss • Stage 4: full-thickness skin and tissue loss with visible fascia, muscle, tendon, ligament, cartilage or bone • Unstageable pressure injury: full-thickness skin and tissue loss that is obscured by slough or eschar so that the severity of injury cannot be confirmed • Deep tissue pressure injury: local injury of persistent, nonblanchable deep red, maroon, purple discolouration or epidermal separation revealing a dark wound bed or bloodfilled blister

The stages described above are consistent with those described in another commonly used system, the International Classification of Diseases for Mortality and Morbidity Statistics (World Health Organization 2019).

Pressure ulcers are complex wounds that are relatively common, a ecting people across di erent care settings. A systematic review found that prevalence estimates for people a ected by pressure ulcers in communities of the UK, USA, Ireland, and Sweden ranged from 5.6 to 2300 per 10,000 depending on the nature of the population surveyed (Cullum 2016). A subsequent cross-sectional survey of people receiving community health services in one city in the UK estimated that 1.8 people per 10,000 have a pressure ulcer (Gray 2018 ).

Pressure ulcers confer a heavy burden in terms of personal impact and use of health-service resources. Having a pressure ulcer may impair physical, social and psychological activities (Gorecki 2009). Ulceration impairs health-related quality of life (Essex 2009); can result in longer institution stays (Theisen 2012); and increases the risk of systemic infection (Espejo 2018) . There is also substantial impact on health systems: a 2015 systematic review of 14 studies across a range of care settings in Europe and North America showed that costs related to pressure ulcer treatment ranged from EUR 1.71 to EUR 470.49 per person, per day (Demarré 2015). In the UK, the annual average cost to the National Health Service for managing one person with a pressure ulcer in the community was estimated to be GBP 1400 for a Stage 1 pressure ulcer and more than GPB 8500 for more severe stages (2015 /2016 Guest 2018) . In Australia, the annual cost of treating pressure ulcers was estimated to be AUD 983 million (95% confidence interval (CI) 815 million to 1151 million) at 2012/2013 prices (Nguyen 2015) . The serious consequences of pressure ulceration have led to an intensive focus on their prevention.

Pressure ulcers are considered largely preventable. Support surfaces are specialised medical devices designed to relieve or redistribute pressure on the body, or both, in order to prevent pressure ulcers (NPIAP S3I 2007) . Types of support surface include, but are not limited to, integrated bed systems, mattresses and overlays (NPIAP S3I 2007) .

The NPIAP Support Surface Standards Initiative (S3I) system (NPIAP S3I 2007) can be used to classify types of support surface. According to this system, support surfaces may:

• be powered (i.e. require electrical power to function) or nonpowered; • passively redistribute body weight (i.e. reactive pressure redistribution), or mechanically alternate the pressure on the body to reduce the duration of pressure (i.e. active pressure redistribution); • be made of a range of materials, including but not limited to: air cells, foam materials, fibre materials, gel materials, sheepskin for medical use and water-bags; or • be constructed of air-filled cells that have small holes on the surface for blowing out air to dry skin (i.e. low-air-loss feature) or have fluid-like characteristics via forcing filtered air through ceramic beads (i.e. air-fluidised feature), or have neither of these features.

Full details of classifications of support surfaces are listed in Appendix 1. Reactive support surfaces cover a spectrum of commonly used beds or mattresses. Reactive air mattresses and reactive foam mattresses are the subject of other, related reviews. This review focuses on non-foam and non-air-filled reactive support surfaces, which includes reactive beds or mattresses made from fibre, gel, sheepskin, water-bags or other materials (NPIAP S3I 2007) . These beds or mattresses are commonly non-powered and aim to passively redistribute pressure over a larger contact area. Examples of types of alternative reactive mattresses include:

• non-powered reactive fibre mattresses (e.g. Spenco overlay);

• non-powered reactive gel mattresses;

• non-powered reactive sheepskin mattresses (e.g. Australian Medical Sheepskins overlay); and • non-powered reactive water mattresses.

The aim of using support surfaces to prevent pressure ulceration is to redistribute pressure beneath the body, thereby allowing blood to flow to tissues and minimising distortion of the skin and so tissue (Wounds International 2010) . Reactive support surfaces achieve pressure redistribution by passive mechanisms, including immersion (i.e. 'sinking' of the body into a support surface) and envelopment (i.e. conforming of a support surface to the irregularities in the body). These devices distribute the pressure over a greater area, thereby reducing the magnitude of the pressure at specific sites (Clark 2011).

Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews publication of the Cochrane Review, 'Support surfaces for pressure ulcer prevention' (McInnes 2015) , there has been a substantial increase in the number of relevant randomised controlled trials published in this area. The NPIAP S3I 2007 support surface-related terms and definitions have also been internationally recognised, and Cochrane has developed new methodological requirements, such as the use of GRADE assessments (Guyatt 2008) . These developments necessitate an update of the evidence base.

In considering this evidence update, we took into account the size and complexity of the published review (McInnes 2015) , which included all types of support surface. An alternative approach is to split the review into multiple new titles, each with a narrower focus. We consulted on this splitting option via an international survey in August 2019. The potential new titles suggested were based on clinical use, the new terms and definitions related to support surfaces (NPIAP S3I 2007) , a relevant network meta-analysis (Shi 2018a), and current clinical practice guidelines (EPUAP/NPIAP/ PPPIA 2019; NICE 2014). We received responses from 29 health professionals involved in pressure ulcer prevention activity in several countries (Australia, Belgium, China, Italy, the Netherlands and the UK). In total, 83% of respondents supported splitting the review into suggested titles and 17% were unsure (no respondent voted against splitting). The reviews in this series are now:

• alternating pressure (active) air surfaces for preventing pressure ulcers; • foam surfaces for preventing pressure ulcers;

• reactive air surfaces for preventing pressure ulcers; and • alternative reactive support surfaces (non-foam and non-airfilled) for preventing pressure ulcers (Di erences between protocol and review).

We will bring the results of these reviews together in an overview with a network meta-analysis (Salanti 2012) , in order to simultaneously compare all support surfaces and to rank them based on the probabilities of each being the most e ective for preventing pressure ulcers. This particular review compares any type of alternative reactive beds, mattresses or overlays that are non-foam and non-air-filled with any other surface.

To assess the e ects of non-foam and non-air-filled reactive beds, mattresses or overlays compared with any other support surface on the incidence of pressure ulcers in any population in any setting.

We included published and unpublished randomised controlled trials (RCTs), including multi-armed studies, cluster-RCTs and crossover trials, regardless of the language of publication. We excluded studies using quasi-random allocation methods (e.g. alternation).

We included studies in any population, including those defined as being at risk of ulceration, as well as those with existing pressure ulcers at baseline (when the study measured pressure ulcer incidence).

The eligible experimental interventions were reactive beds, mattresses or overlays that were non-foam and non-air-filled. These surfaces included, but were not limited to, specific reactive mattresses identified in Shi 2018a, namely:

• non-powered reactive fibre mattresses (e.g. Silicore fibre overlay); or • non-powered reactive gel mattresses (e.g. a gel pad used on an operating table); or • non-powered reactive sheepskin mattresses (e.g. Australian Medical Sheepskins overlay); or • non-powered reactive water mattresses.

We included studies where two or more support surfaces were used sequentially over time or in combination, where the support surface(s) of interest was included in one of the study arms. We included studies comparing eligible non-foam and non-air-filled beds, overlays or mattresses with any comparator defined as a support surface. Comparators could be:

• foam-filled or air-filled surfaces, including alternating pressure (active) air surfaces such as alternating pressure (or dynamic) air mattresses, reactive air surfaces (e.g. static air overlays, dry flotation mattresses, air-fluidised beds), and foam mattresses, or • a di erent type of non-foam or non-air-filled surface.

We included studies in which co-interventions (e.g. repositioning) were delivered, provided that the co-interventions were the same in all arms of the study (i.e. interventions randomised were the only systematic di erence).

We considered the following primary and secondary outcomes. If a study did not report any review-relevant outcomes but was otherwise eligible (i.e. eligible study design, participants and interventions), we contacted the study authors (where possible) to clarify whether they measured a relevant outcome but did not report it. We considered the study as 'awaiting classification' if we could not establish whether it measured an outcome or not. We excluded the study if the study authors confirmed that they did not measure any review-relevant outcomes.

If a study measured an outcome at multiple time points, we considered outcome measures at three months as being of primary interest to this review (Schoonhoven 2007) , regardless of the time points specified as being of primary interest by the study. If the study did not report three-month outcome measures, we considered those closest to three months. Where a study only reported a single time point, we considered these data in this review. Where the study did not specify a time point for outcome measurement, we assumed this was the final duration of follow-up noted.

Our primary outcome was pressure ulcer incidence. We recorded two outcome measures (the proportion of participants developing a new pressure ulcer; and time to pressure ulcer incidence), where available. However, we considered the proportion of participants developing a new pressure ulcer as the primary outcome for Library Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews this review. Our preferred measure was time to pressure ulcer incidence; however, we did not expect it to be reported in many studies. We extracted and analysed time-to-event data but focused on the binary outcome in our conclusions. We accepted the study authors' definitions of an incident ulcer regardless of which pressure ulcer severity classification system was used to measure or grade new pressure ulcers. We also considered the outcome of pressure ulcer incidence irrespective of whether studies reported ulcers by stages or as a non-stratified value.

We did not consider subjective outcome measures (e.g. 'better' or 'worse' skin condition) as measures of pressure ulcer incidence.

• Support-surface-associated patient comfort. We considered patient comfort outcome data in this review only if the evaluation of patient comfort was pre-planned and was systematically conducted across all participants in the same way in a study. The definition and measurement of this outcome varied from one study to another; for example, the proportion of participants who report comfort, or comfort measured by a scale with continuous (categorical) numbers. We planned to include these data with di erent measurements in separate meta-analyses when possible. • All reported adverse events (measured using surveys or questionnaires, other data capture process or visual analogue scale). We included data where study authors specified a clear method for collecting adverse event data. Where available, we extracted data on all serious and all non-serious adverse events as an outcome. We recorded where it was clear that events were reported at the participant level or whether multiple events per person were reported, in which case appropriate adjustments were required for data clustering (Peryer 2019). We considered the assessment of any event in general defined as adverse by participants, health professionals, or both. • Health-related quality of life (measured using a standardised generic questionnaire such as EQ-5D (Herdman 2011) , 36item Short Form (SF-36; Ware 1992), or pressure ulcer-specific questionnaires such as the PURPOSE Pressure Ulcer Quality of Life (PU-QOL) questionnaire (Gorecki 2013), at noted time points. We did not include ad hoc measures of quality of life or qualitative interviews of quality of life because these measures were unlikely to be validated. • Cost-e ectiveness: within-trial cost-e ectiveness analysis comparing mean di erences in e ects with mean cost di erences between the two arms. We extracted data on incremental mean cost per incremental gain in benefit (incremental cost-e ectiveness ratio (ICER)). We also considered other measures of relative cost-e ectiveness (e.g. net monetary benefit, net health benefit).

We searched the following electronic databases to identify reports of relevant clinical trials:

• We identified other potentially eligible studies or ancillary publications by searching the reference lists of retrieved included studies, as well as relevant systematic reviews, meta-analyses and health technology assessment reports.

When necessary, we contacted authors of key papers and abstracts to request further information about their trials.

We did not perform a separate search for adverse e ects of interventions used; we considered adverse e ects described in included studies only.

We carried out data collection and analysis according to the methods stated in the published protocol (Shi 2020), which were based on the Cochrane Handbook for Systematic Reviews of Interventions (Li 2019). Changes from the protocol or previous published versions of the review are documented in Di erences between protocol and review.

One review author re-checked the RCTs included in McInnes 2015 for eligibility (CS). Two review authors or researchers (CS and Asmara Jammali-Blasi, or JCD) independently assessed the titles and abstracts of the new search results for relevance using Rayyan (Ouzzani 2016) (Di erences between protocol and review), and then independently inspected the full text of all potentially eligible studies. The two review authors or researchers (CS and Asmara Jammali-Blasi, or JCD) resolved disagreements through discussion or by involving another review author if necessary.

One review author checked data from the studies included in McInnes 2015 and extracted additional data where necessary (CS). A second review author or researcher (SR, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked any new data extracted.

For new included studies, one review author (CS) independently extracted data and another review author or researcher (SR, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked all data (Di erences between protocol and review). Any disagreements were resolved through discussion and, if necessary, with the involvement of another review author. Where necessary, we contacted the authors of included studies to clarify data.

We extracted these data using a pre-prepared data extraction form:

• basic characteristics of studies (first author, publication type, publication year and country); • funding sources; • care setting; • characteristics of participants (trial eligibility criteria, average age in each arm or in a study, proportions of participants by gender and participants' baseline skin status); • support surfaces being compared (including their descriptions); • details on any co-interventions;

• duration of follow-up; • the number of participants enrolled; • the number of participants randomised to each arm; • the number of participants analysed; • participant withdrawals with reasons; • the number of participants developing new ulcers (by ulcer stages where possible); • data on time to pressure ulceration; • support-surface-associated patient comfort; • adverse event outcome data; • health-related quality of life outcome data; and • cost-e ectiveness outcome data.

We (CS and NC) classified specific support surfaces in the included studies into intervention groups using the NPIAP S3I support surface-related terms and definitions (NPIAP S3I 2007) . Therefore, to accurately assign specific support surfaces to intervention groups, we extracted full descriptions of support surfaces from included studies, and when necessary, supplemented the information with that from external sources such as other publications about the same support surface, manufacturers' or product websites, and expert clinical opinion (Shi 2018b). If we were unable to define any of specific support surfaces evaluated in an included study, we extracted available data and reported these as additional data outside the main review results.

Two review authors or researchers (CS and SR, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) independently assessed risk of bias of each included study using the Cochrane 'Risk of bias' tool (see Appendix 3). This tool has seven specific domains: sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete data (attrition bias), selective outcome reporting (reporting bias), and other issues (Higgins 2017) . We assessed performance bias, detection bias and attrition bias separately for each of the review outcomes (Higgins 2017) . We noted that it is o en impossible to blind participants and personnel in device trials. In this case, performance bias may be introduced if knowledge of treatment allocation results in deviations from intended interventions, di erential use of co-interventions or care between groups not specified in the study protocol that may influence outcomes. We attempted to understand if, and how, included studies compensated for challenges in blinding; for example, implementing strict protocols to maximise consistency of cointerventions between groups to reduce the risk of performance bias. We also noted that pressure ulcer incidence is a subjective outcome. Compared with blinded assessment, non-blinded assessment of subjective outcomes tends to be associated with more optimistic e ect estimates of experimental interventions in RCTs (Hróbjartsson 2012). Therefore, we judged non-blinded outcome assessment as being at high risk of detection bias. In this review, we included the issues of di erential diagnostic activity and unit of analysis under the domain of 'other issues'. For example, unit of analysis issues occurred where a cluster-randomised trial had been undertaken but analysed at the individual level in the study report.

For the studies included in McInnes 2015, one review author (CS) checked the 'Risk of bias' judgements and, where necessary, updated them. A second review author or researcher (SR, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked any updated judgement. We assigned each 'Risk of bias' domain a judgement of high, low, or unclear risk of bias. We resolved any discrepancy through discussion and by involving another review author where necessary. Where possible, useful and feasible, when a lack of reported information resulted in a judgement of unclear risk of bias, we planned to contact study authors for clarification.

We present our assessment of risk of bias for the proportion of participants developing a new pressure ulcer outcome using two 'Risk of bias' summary figures: one is a summary of bias for each item across all studies, and the second shows a cross-tabulation of each study by all of the 'Risk of bias' items.

Once we had given our judgements for all 'Risk of bias' domains, we judged the overall risk of bias for each outcome across studies as:

• low risk of bias, if we judged all domains to be at low risk of bias;

• unclear risk of bias, if we judged one or more domains to be at unclear risk of bias and other domains were at low risk of bias but no domain was at high risk of bias; or • high risk of bias, as long as we judged one or more domains as being at high risk of bias, or all domains had unclear 'Risk of bias' Cochrane Database of Systematic Reviews judgements, as this could substantially reduce confidence in the result.

We resolved any discrepancy between two review authors through discussion and by involving another review author where necessary. For studies using cluster randomisation, we planned to consider the risk of bias in relation to recruitment bias, baseline imbalance, loss of clusters, incorrect analysis and comparability with individually randomised studies (Eldridge 2019; Higgins 2019) (Appendix 3). However, we did not include any studies with a cluster design.

For meta-analysis of pressure ulcer incidence data, we present the risk ratio (RR) with its 95% confidence interval (CI). For continuous outcome data, we present the mean di erence (MD) with 95% CIs for studies that use the same assessment scale. If studies reporting continuous data used di erent assessment scales, we planned to report the standardised mean di erence (SMD) with 95% CIs. However, this was not undertaken in the review.

For time-to-event data (time to pressure ulcer incidence), we present the hazard ratio (HR) with its 95% CI. If included studies reporting time-to-event data did not report an HR, when feasible, we estimated this using other reported outcomes (such as numbers of events) through employing available statistical methods (Parmar 1998; Tierney 2007) .

We noted whether studies presented outcomes at the level of cluster (e.g. ward, research site) or at the level of participants. We also recorded whether the same participant was reported as having multiple pressure ulcers.

Unit of analysis issues may occur if studies randomise at the cluster level but the incidence of pressure ulcers is observed and data are presented and analysed at the level of participants (clustered data). We noted whether data regarding participants within a cluster were (incorrectly) treated as independent within a study, or were analysed using within-cluster analysis methods. If clustered data were incorrectly analysed, we recorded this as part of the 'Risk of bias' assessment.

If a cluster-RCT was not correctly analysed, we planned to use the following information to adjust for clustering ourselves, where possible, in accordance with guidance in the Cochrane Handbook for Systematic Reviews of Interventions .

• The number of clusters randomly assigned to each intervention, or the average (mean) number of participants per cluster. • Outcome data, ignoring the cluster design for the total number of participants. • Estimate of the intra-cluster (or intra-class) correlation coe icient (ICC).

For cross-over trials, we only considered outcome data at the first intervention phase (i.e. prior to cross-over) as eligible.

If a study had more than two eligible study groups, where appropriate, we combined results across these arms to make single pair-wise comparisons .

Data are commonly missing from study reports. Reasons for missing data could be the exclusion of participants a er randomisation, withdrawal of participants from a study, or loss to follow-up. The exclusion of these data from analysis may break the randomisation and potentially introduces bias.

Where there were missing data, and where relevant, we contacted study authors to pose specific queries about these data. In the absence of other information, for pressure ulcer incidence, we assumed that participants with missing data did not develop new pressure ulcers for the main analysis (i.e. we added missing data to the denominator but not the numerator). We examined the impact of this assumption through undertaking a sensitivity analysis (see Sensitivity analysis). When a study did not specify the number of randomised participants prior to dropout, we used the available number of participants as the number randomised.

Assessing heterogeneity can be a complex, multifaceted process. Firstly, we considered clinical and methodological heterogeneity; that is, the extent to which the included studies varied in terms of participant, intervention, outcome and other characteristics including duration of follow-up, clinical settings and overall studylevel 'Risk of bias' judgement (Deeks 2019). In terms of the duration of follow-up, in order to assess the relevant heterogeneity, we recorded and categorised assessment of outcome measures as follows:

• up to eight weeks (short-term);

• more than eight weeks to 16 weeks (medium-term); and • more than 16 weeks (long-term).

We supplemented this assessment of clinical and methodological heterogeneity with information regarding statistical heterogeneity assessed using the Chi 2 test. We considered a P value of less than 0.10 to indicate statistically significant heterogeneity given that the Chi 2 test has low power, particularly in the case where studies included in a meta-analysis have small sample size. We carried out this statistical assessment in conjunction with the I 2 statistic (Higgins 2003) , and the use of prediction intervals for randome ects meta-analyses (Borenstein 2017; Riley 2011).

The I 2 statistic is the percentage of total variation across studies due to heterogeneity rather than chance (Higgins 2003) . Very broadly, we considered that I 2 values of 25% or less may indicate a low level of heterogeneity and values of 75% or more may indicate very high heterogeneity (Higgins 2003) . For random-e ects models where the meta-analysis had more than 10 included studies and no clear funnel plot asymmetry, we also planned to present 95% prediction intervals (Deeks 2019). We planned to calculate prediction intervals following methods proposed by Borenstein 2017.

Random-e ects analyses produce an average treatment e ect, with 95% confidence intervals indicating where the true population average value is likely to lie. Prediction intervals quantify variation It is important to note that prediction intervals reflect heterogeneity of any source, including from methodological issues as well as clinical variation. For this reason some authors have suggested that prediction intervals are best calculated for studies at low risk of bias to ensure intervals that have meaningful clinical interpretation (Riley 2011). We had planned to calculate prediction intervals for all analyses to assess heterogeneity and then to explore the impact of risk of bias in subgroup analysis stratified by study risk of bias assessment as detailed below. However, we did not calculate any prediction intervals because all conducted metaanalyses contained fewer than 10 studies.

We followed the systematic framework recommended by Page 2019 to assess risk of bias due to missing results (non-reporting bias) in the meta-analysis of pressure ulcer incidence data. To make an overall judgement about risk of bias due to missing results, we did the following.

• Identified whether pressure ulcer incidence data were unavailable by comparing the details of outcomes in trials registers, protocols or statistical analysis plans (if available) with reported results. If the above information sources were unavailable, we compared outcomes in the conference abstracts or in the methods section of the publication, or both, with the reported results. If we found non-reporting of study results, we then judged whether the non-reporting was associated with the nature of findings by using the 'Outcome Reporting Bias In Trials' (ORBIT) system (Kirkham 2018). • Assessed the influence of definitely missing pressure ulcer incidence data on meta-analysis. • Assessed the likelihood of bias where a study had been conducted but not reported in any form. For this assessment, we considered whether the literature search was comprehensive and planned to produce a funnel plot for meta-analysis for seeking more evidence about the extent of missing results, provided there were at least 10 included studies (Peters 2008; Salanti 2014).

However, we did not produce a funnel plot for any meta-analysis because all analyses in this review had fewer than 10 included studies.

We summarised the included studies narratively and synthesised included data by using meta-analysis where applicable. We structured comparisons according to type of comparator and then by outcomes, ordered by follow-up period.

We considered clinical and methodological heterogeneity and undertook pooling when studies appeared appropriately similar in terms of participants, support surfaces and outcome type. Where statistical synthesis of data from more than one study was not possible or considered inappropriate, we conducted a narrative review of eligible studies.

Once the decision to pool was made, we used a random-e ects model, which estimated an underlying average treatment e ect from studies. Conducting meta-analysis with a fixed-e ect model in the presence of even minor heterogeneity may provide overly narrow confidence intervals. We used the Chi 2 test and I 2 statistic to quantify heterogeneity but not to guide choice of model for meta-analysis (Borenstein 2009). We exercised caution when metaanalysed data were at risk of small-study e ects because use of a random-e ects model may be unsuitable in this situation. In this case, or where there were other reasons to question the choice of a fixed-e ect or random-e ects model, we assessed the impact of the approach using sensitivity analyses to compare results from alternate models (Thompson 1999).

We performed meta-analyses largely using Review Manager 5.4 (Review Manager 2020). We presented data using forest plots where possible. For dichotomous outcomes, we presented the summary estimate as a RR with 95% CIs. Where continuous outcomes were measured, we presented the MD with 95% CIs. We planned to report SMD estimates where studies measured the same outcome using di erent methods. For time-to-event data, we presented the summary estimates as HRs with 95% CIs.

When important heterogeneity occurred, we planned to follow steps proposed by Cipriani 2013 and Deeks 2019 to investigate further:

• check the data extraction and data entry for errors and possible outlying studies; • if outliers existed, perform sensitivity analysis by removing them; and • if heterogeneity was still present, we planned to perform subgroup analyses for study-level characteristics (see below) in order to explain heterogeneity as far as possible. However, we did not undertake any subgroup analysis because metaanalyses in this review included fewer than 10 studies.

We investigated heterogeneity using the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (Deeks 2019). We planned to perform subgroup analyses for binary and categorical factors (or meta-regression for continuous factors) to determine whether the size of treatment e ects was influenced by these four study-level characteristics:

• risk of bias (binary: low or unclear risk of bias; and high risk of bias (Schulz 1995)); • settings (categorical: acute care and other hospital settings; long-term care settings; operating theatre setting; and intensive care unit); • baseline skin status (categorical: participants at risk, of mixed skin status or non-reporting; non-blanchable erythema; existing ulcers of Stage 2 or serious (Shi 2018c)); and • follow-up duration (continuous).

We planned to compare subgroup findings using the 'Test for Subgroup Di erences' in Review Manager 5.4 (Review Manager 2020). We did not perform subgroup analysis/meta-regression Library Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews when the number of studies included in the meta-analysis was not reasonable (i.e. fewer than 10).

We conducted sensitivity analyses for the following factors, to assess the robustness of meta-analysis of data on pressure ulcer incidence.

• Impact of the selection of pressure ulcer incidence outcome measure. The proportion of participants developing a new pressure ulcer was the primary outcome measure for this review but we also analysed time to pressure ulcer incidence, where data were available. • Impact of missing data. The primary analysis assumed that participants with missing data did not develop new pressure ulcers. We also analysed pressure ulcer incidence by only including data for the participants for whom we had endpoint data (complete cases). We noted that when a study only had complete case data (i.e. missing data or the numbers of participants randomised were not reported), complete case data were considered in the related main analysis (Di erences between protocol and review). • Impact of using a fixed-e ect model instead of a random-e ects model.

We presented the main, pooled results of the review in 'Summary of findings' tables, which we created using GRADEpro GDT so ware. These tables present key information concerning the certainty of evidence, the magnitude of the e ects of the interventions examined and the sum of available data for the main outcomes (Schünemann 2019). The tables also include an overall grading of the certainty of the evidence associated with each of the main outcomes that we assessed using the GRADE approach. The GRADE approach defines the certainty of a body of evidence as the extent to which one can be confident that an estimate of e ect or association is close to the true quantity of specific interest.

The GRADE assessment involves consideration of five factors: within-trial risk of bias, directness of evidence, heterogeneity, precision of e ect estimates, and risk of publication bias (Schünemann 2019). The certainty of evidence can be assessed as being high, moderate, low or very low; RCT evidence has the potential to be high-certainty. We did not downgrade the certainty of evidence for the risk of bias factor in a specific circumstance. That is, if the blinding of participants and personnel was the only domain resulting in our judgement of overall high risk of bias for the included studies; however for these studies it was impossible to blind participants and personnel.

When downgrading for imprecision, we followed the methods described in Guyatt 2011: either considering both the optimal information size (OIS) and the 95% CI of each meta-analysis if they were estimable; or considering the sample size, the number of events and other e ectiveness indicators if the calculation of OIS and undertaking a meta-analysis were not applicable. Where necessary, we used the GRADE 'default' minimum important di erence values (e.g. RR = 1.25 and 0.75) as the thresholds to judge if a 95% CI was wide (imprecise) so as to include the possibility of clinically important harm and benefit (Guyatt 2011 ).

We presented a separate 'Summary of findings' table for all key comparisons evaluated in this review. Six comparisons had no analysis and we did not present 'Summary of findings' tables for these. These comparisons were: reactive water surfaces versus foam surfaces, reactive water surfaces versus reactive fibre surfaces, reactive gel surfaces versus reactive gel surfaces, reactive gel surfaces versus foam surfaces, reactive foam and gel surfaces versus reactive gel surfaces, and reactive foam and gel surfaces versus foam surfaces (Di erences between protocol and review). We presented these outcomes in the 'Summary of findings' tables:

• proportion of participants developing a new pressure ulcer;

• time to pressure ulcer incidence;

• support-surface-associated patient comfort;

• all reported adverse events;

• health-related quality of life; and • cost-e ectiveness.

We prioritised the time points and method of outcome measurement specified in Types of outcome measures for presentation in 'Summary of findings' tables. Where we did not pool data for some outcomes within a comparison, we conducted a GRADE assessment for each of these outcomes and presented these assessments in a narrative format in 'Summary of findings' tables (Di erences between protocol and review).

See Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification; Characteristics of ongoing studies.

The electronic searches identified 1624 records, including 1164 from electronic databases and 460 from trials registries. We excluded 218 duplicate records and screened 1412 records, of which 234 were identified as potentially eligible and obtained as full-text. Following full-text screening, we considered 34 records of 20 studies eligible for inclusion in this review (Andersen 1982; Aronovitch 1999; Bliss 1995a; Cassino 2013a; Conine 1990; Daechsel 1985; Ewing 1964; Hoshowsky 1994; IRCT2015110619919N3; Jolley 2004; Lazzara 1991; McGowan 2000; Mistiaen 2010; Nixon 1998; Ricci 2013; Russell 2000; Sideranko 1992 ; Stapleton 1986; Van Leen 2018; Vermette 2012).

We identified no additional studies from other resources. Of the 20 studies, IRCT2015110619919N3 was a trials registry record. See Cochrane Database of Systematic Reviews

Included studies

Of the 20 included RCTs, 18 had a parallel group design: 15 with two arms, and three with three arms. Two studies had particular design features:

• Bliss 1995a appeared to be a multi-arm, multi-stage trial design with eight arms, of which seven were randomised and eligible for this review; • Hoshowsky 1994 was a split body design (that is, it randomly allocated di erent support surfaces to either the right or le half of the body of the same person) and three of its six arms included foam surfaces.

Six of 20 studies were conducted at more than one research site In the 16 studies that clearly stated duration of follow-up, the median was four weeks (range: seven days to six months).

Of the 20 studies, 19 enrolled a total of 4653 participants (median study sample size: 198 participants; range: 32.0 to 588.0) whilst one (IRCT2015110619919N3) did not specify the number of participants. The average participant age was specified for 17 studies and ranged between 37.2 and 85.4 years (median: 72.5 years). The sex of participants was specified for 17 studies; and within these, 1708 (43.0%) of participants were male and 2262 (57.0%) were female.

Of the 20 studies, 16 (4040 participants) recruited people at risk of having a new ulcer with risk assessed largely using the Waterlow, Norton or Braden scales. In 13 of these studies, 3087 (76.4%) participants were free of pressure ulcers at baseline. In three studies, 953 (23.6%) participants with superficial ulcers were enrolled (Bliss 1995a; Nixon 1998; Ricci 2013) . In one study (Cassino 2013a), people with severe full-thickness pressure ulcers were enrolled. Three studies did not specify participants' skin status at baseline (Ewing 1964; Hoshowsky 1994; IRCT2015110619919N3) .

Participants were from a variety of settings, including: 

The 20 included studies investigated a wide range of non-air and non-foam-filled surfaces, including:

• reactive water surfaces (Andersen 1982; Bliss 1995a; Sideranko 1992); • reactive fibre surfaces (Bliss 1995a; Conine 1990; Daechsel 1985;  Stapleton 1986); Cochrane Database of Systematic Reviews

• two types of non-air and non-foam-filled surfaces that we could not define using NPIAP S3I support surfaces terms and definitions: the Bedcare (Sense Textile, 's-Hertogenbosch) multilayer mattress system used in Van Leen 2018 and the RIK® microfluid static overlays used in Vermette 2012.

In terms of control surfaces, we could classify the surfaces used in 11 of the 20 studies using the NPIAP S3I support surfaces terms and definitions. The following control surfaces in the remaining nine studies could not be classified further: the Aiartex® overlays evaluated in two studies (122 participants; Cassino 2013a; Ricci 2013) and 'standard hospital surfaces' evaluated in seven studies (2386 participants; Andersen 1982; Ewing 1964; IRCT2015110619919N3; Jolley 2004; McGowan 2000; Mistiaen 2010; Nixon 1998) . We used the term 'standard hospital surfaces' to cover 'usual care', 'standard mattress', 'standard operating table mattress', and 'any other pressure-relieving devices' which were the terms used by the authors of these seven studies.

Full details of these interventions and comparators are listed in E ects of interventions below.

Nine studies specified co-interventions they applied (e.g. repositioning, cushions). All but two of these stated or indicated that the same co-interventions were applied in all study groups. The two exceptions applied heel protectors or usual care in participants allocated to experimental arms but this was not specified in the control arms (McGowan 2000; Mistiaen 2010) . We assumed such co-interventions were also applied for control participants.

Of the 20 studies, 16 specified the details of funding sources. Ten studies were completely or partly funded by industry or received the mattresses under evaluation from industries (Aronovitch 1999; Bliss 1995a; Cassino 2013a; Daechsel 1985; Jolley 2004; Lazzara 1991; McGowan 2000; Ricci 2013; Russell 2000; Van Leen 2018) .

Vermette 2012 noted no funding support. Public or charity funding supported the four remaining studies (Conine 1990; Mistiaen 2010; Nixon 1998; Stapleton 1986) .

We excluded 151 studies (with 186 records). The main reasons for exclusion were: irrelevant and ineligible interventions (64 studies); ineligible study design (e.g. non-RCT, reviews, commentary articles; 52 studies); studies focused on the treatment rather than prevention of pressure ulcers (20 studies); non-randomised methods (eight studies); studies with ineligible outcomes (four studies); clinical trials that were withdrawn (two studies; NCT02634892; NCT02735135); and ineligible participants (healthy subjects; one study). We also identified eight duplicates in screening the full-texts (see Figure 1 ).

We did not identify any ongoing studies.

We were unable to make eligibility decisions for six studies (six records). We were unable to determine whether Gardner 2008 measured one or more outcomes relevant to this review. We could not obtain the full-text of five studies -in part due to more limited access to intra-library loans during the COVID-19 period -despite extensive e orts made (Chaloner 2000; Henn 2004; Knight 1999; Mastrangelo 2010a; Melland 1998 Cochrane Database of Systematic Reviews

Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants and personnel (performance bias): All outcomes Blinding of outcome assessment (detection bias): All outcomes Incomplete outcome data (attrition bias): All outcomes Selective reporting (reporting bias) Other bias

Random sequence generation (selection bias) Allocation concealment (selection bias) Blinding of participants and personnel (performance bias): All outcomes Blinding of outcome assessment (detection bias): All outcomes Incomplete outcome data (attrition bias): All outcomes Selective reporting ( 

We ran a comprehensive search and consider the risk of having missed published reports to be low. We were able to locate one trial registry report (IRCT2015110619919N3). We were unable to assess for the risk of non-publication of studies with negative findings as we could not present funnel plots given the small number of included studies in each analysis.

See: Summary of findings 1 Reactive water surfaces compared with alternating pressure (active) air surfaces for preventing pressure ulcers; Summary of findings 2 Reactive water surfaces compared with reactive air surfaces for preventing pressure ulcers; Summary of findings 3 Reactive fibre surfaces compared with alternating pressure (active) air surfaces for preventing pressure ulcers; Summary of findings 4 Reactive fibre surfaces compared with foam surfaces for preventing pressure ulcers; Summary of findings 5 Reactive gel surfaces on operating tables followed by foam surfaces on ward beds compared with alternating pressure (active) air surfaces on operating tables and subsequently on ward beds for preventing pressure ulcers; Summary of findings 6 Reactive gel surfaces compared with reactive air surfaces for preventing pressure ulcers See Summary of findings 1; Summary of findings 2; Summary of findings 3; Summary of findings 4; Summary of findings 5; Summary of findings 6.

Unless otherwise stated, random-e ects analysis was used throughout. Each pooled result presented is an average e ect, rather than a common e ect and should be interpreted as such.

We did not pool data involving undefined non-foam and non-airfilled surfaces or undefined control surfaces in the main body of the results (10 studies noted above). For completeness, we summarise the results of these studies in Appendix 4.

We performed data analyses for the following comparisons and outcomes. Where applicable, we performed pre-specified sensitivity analyses as noted in Sensitivity analysis.

Three studies compared reactive water surfaces with alternating pressure (active) air surfaces (Andersen 1982; Bliss 1995a; Sideranko 1992) . Bliss 1995a (56 participants) reported the outcome of the numbers of treatment sessions in which pressure ulcers developed or worsened, which we considered not directly relevant to this review.

Proportion of participants developing a new pressure ulcer (median follow-up duration 10.0 days, minimum 10.0 days, maximum 17.7 days)

We pooled available data from two studies (358 participants; Andersen 1982; Sideranko 1992). It is uncertain whether there is a di erence in the proportion of participants developing a new pressure ulcer between reactive water surfaces (9/172 (5.2%)) and alternating pressure (active) air surfaces (12/186 (6.5%)). The RR is 0.83 (95% CI 0.35 to 1.93; I 2 = 0%; Analysis 1.1). Evidence is of very low certainty, downgraded twice for high risk of detection bias in one study contributing over 60% weight in the meta-analysis and unclear overall risk of bias in another study, and twice for substantial imprecision as the optimal information size (OIS) was not met and the very wide confidence interval crossed RR = 0.75 and 1.25, which includes the possibility of both harm and benefit as well as no e ect.

The included studies did not report data on time to pressure ulcer incidence.

Trusted evidence. Informed decisions. Better health.

We considered the studies heterogeneous in terms of care setting, and overall risk of bias. However, we did not perform any prespecified subgroup analysis because, as noted in Subgroup analysis and investigation of heterogeneity, the number of included studies was fewer than 10, meaning it would be di icult to meaningfully interpret the results.

• Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 0.83 (95% CI 0.36 to 1.90; I 2 = 0%). The result remained consistent with the main analysis (Appendix 5).

None reported.

Bliss 1995a compared reactive water surfaces with foam surfaces but reported no outcomes directly relevant to this review and so none of the data were analysable.

Sideranko 1992 compared reactive water surfaces with reactive air surfaces.

Proportion of participants developing a new pressure ulcer (follow-up duration 9.5 days)

Sideranko 1992 (37 participants) reported this outcome. It is uncertain if there is a di erence in the proportion of participants developing a new ulcer between reactive water surfaces (2/17 (11.8%)) and reactive air surfaces (1/20 (5%)). The RR is 2.35 (95% CI 0.23 to 23.75; Analysis 2.1). Evidence is of very low certainty, downgraded once for unclear overall risk of bias and twice for substantial imprecision because the OIS was not met and the very wide confidence interval crossed RRs = 0.75 and 1.25, which failed to exclude important benefits or harms as well as no e ect.

The included study did not report data on time to pressure ulcer incidence.

None reported.

Bliss 1995a compared reactive water surfaces with reactive fibre surfaces but reported no outcomes directly relevant to this review and so none of the data were analysable.

Four studies made this comparison (Bliss 1995a; Conine 1990; Daechsel 1985; Stapleton 1986) , of which Bliss 1995a randomised participants into two types of fibre surfaces (in two individual study arms) that we combined into a single study arm. Bliss 1995a reported the outcome of the numbers of treatment sessions in which pressure ulcers developed or worsened, which we considered not directly relevant to this review.

Proportion of participants developing a new pressure ulcer (minimum follow-up duration 17.7 days, maximum three months or unspecified)

We pooled the data from three studies (285 participants) for this outcome (Conine 1990; Daechsel 1985; Stapleton 1986) . It is uncertain whether there is a di erence in the proportion of participants developing a new pressure ulcer between reactive fibre surfaces (61/144 (42.4%)) and alternating pressure (active) air surfaces (54/141 (38.3%)). The RR is 1.11 (95% CI 0.84 to 1.47; I 2 = 0%; Analysis 3.1). Evidence is very low certainty, downgraded twice for high risk of bias in domains other than performance bias in two studies contributing over 80% weight to the meta-analysis, and once for imprecision as the 95% CI crossed RR = 1.25.

The included studies did not report data on time to pressure ulcer incidence.

We considered these studies heterogeneous in terms of care settings, participants' average age and skin status at baseline. However, we did not perform any pre-specified subgroup analysis because, as noted in Subgroup analysis and investigation of heterogeneity, the number of included studies was fewer than 10, meaning it would be di icult to meaningfully interpret the results.

• Sensitivity analysis using complete case data . This resulted in a RR of 1.08 (95% CI 0.84 to 1.39; I 2 = 0%). The result was consistent with the main analysis (Appendix 5). • Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 1.11 (95% CI 0.84 to 1.47; I 2 = 0%) and the result remained consistent with the main analysis (Appendix 5).

Support-surface-associated patient comfort (follow-up duration three months)

Only Conine 1990 (187 participants) reported this outcome. We are uncertain about any di erence between reactive fibre surfaces and alternating pressure (active) air surfaces in patient comfort responses. Conine 1990 reported 17 dropouts among 94 people using reactive fibre surfaces and 19 of 93 using alternating pressure (active) air surfaces. The reason for dropout was given as discomfort. This was very low certainty evidence, downgraded once for unclear overall risk of bias for this outcome, once for indirectness as the reported outcome was indirectly relevant to this review, and once for imprecision.

Not reported.

Not reported.

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( 

Cost-e ectiveness Not reported.

Bliss 1995a and Stapleton 1986 compared foam surfaces with reactive fibre surfaces, of which Bliss 1995a reported no outcomes directly relevant to this review and so none of the data were analysable.

Proportion of participants developing a new pressure ulcer (follow-up duration unspecified)

Stapleton 1986 (68 participants) reported data for this outcome. It is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between reactive fibre surfaces (12/34 (35.3%)) and foam surfaces (14/34 (41.2%)). The RR is 0.86 (95% CI 0.47 to 1.57; Analysis 4.1). The evidence is of very low certainty, downgraded twice for unclear risk of bias in all domains, and twice for imprecision as the OIS was not met and the wide confidence interval crossed RRs = 0.75 and 1.25.

The included study did not report data on time to pressure ulcer incidence.

None reported.

Two studies (415 participants) were included in this comparison (Aronovitch 1999; Russell 2000) .

Both studies (415 participants) reported this outcome (Aronovitch 1999; Russell 2000) and these data were pooled. Reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds (14/205 (6.8%)) may increase the proportion of people developing a new pressure ulcer compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds (3/210 (1.4%)). However, the evidence is of low certainty. The RR is 4.53 (95% CI 1.31 to 15.65; I 2 = 0%; Analysis 5.1). Evidence certainty was downgraded once for risk of bias (one study contributing 36% of weight to the metaanalysis was at high risk of attrition bias whilst the other study was at unclear risk of bias for more than one domain other than performance bias) and once for imprecision as, despite the fact that the OIS was met, the confidence interval was very wide (imprecise).

The included studies did not report data on time to pressure ulcer incidence.

We considered both studies similar in terms of care settings, followup duration, overall risk of bias, participant characteristics and interventions: statistical heterogeneity was low (Chi 2 test P value = 0.55; Tau 2 = 0.00; I 2 = 0%). Because the number of included studies was fewer than 10, we did not undertake a subgroup analysis.

• Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 4.74 (95% CI 1.39 to 16.16; I 2 = 0%) and the result remained consistent with the main analysis (Appendix 5).

None reported.

Only Russell 2000 (198 participants) reported this outcome. It is uncertain if there is a di erence in adverse events between reactive gel surfaces followed by foam surfaces and alternating pressure (active) air surfaces. The study authors claimed that approximately one half of people in each group reported one or more types of adverse events, with no di erence between groups reported. The study authors also noted that no adverse events were considered to be related to the mattresses assigned. Evidence is very low certainty, downgraded once for risk of bias in more than one domain other than performance bias, and twice for imprecision due to small sample size.

Not reported.

Not reported.

Lazzara 1991 compared reactive gel surfaces with reactive air surfaces.

Lazzara 1991 (74 participants) reported this outcome and had analysable data for 66 participants. It is uncertain if there is a di erence in the proportion of participants developing a new ulcer between reactive gel surfaces (8/33 (24.2%)) and reactive air surfaces (10/33 (30.3%)). The RR is 0.80 (95% CI 0.36 to 1.77; Analysis 6.1). Evidence is of very low certainty, downgraded once for unclear overall risk of bias and twice for imprecision because the OIS was not met and the very wide confidence interval crossed RRs = 0.75 and 1.25.

The included study did not report data on time to pressure ulcer incidence.

None reported. Cochrane Database of Systematic Reviews

Hoshowsky 1994 was a study with a split body design. Two of its six arms compared reactive gel surfaces on top of another type of surface. These were combined into a single study arm for this comparison and compared with the foam surfaces.

Proportion of participants developing a new pressure ulcer (follow-up duration unspecified)

Hoshowsky 1994 (135 participants) reported this outcome but indicated that no pressure ulcers developed in the trial. It is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between reactive gel surfaces and foam surfaces. The evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias, and twice for imprecision due to the small sample size and the low event rate.

The included study did not report data on time to pressure ulcer incidence.

None reported.

Using a split body design, Hoshowsky 1994 compared reactive gel surfaces (on top of reactive foam and gel surfaces) with reactive gel surfaces (on top of reactive foam surfaces).

Hoshowsky 1994 (113 participants) reported this outcome but indicated that no pressure ulcers developed. It is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between these two types of use of reactive gel surfaces. Evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias, and twice for imprecision due to the small sample size and the low event rate.

The included study did not report data on time to pressure ulcer incidence.

None reported.

Using a split body design, Hoshowsky 1994 made this comparison. We combined two arms receiving a reactive foam and gel surface and compared that combination with the combined study arms receiving reactive gel surfaces on top of other foam surfaces.

Hoshowsky 1994 (166 participants) reported this outcome but indicated that no pressure ulcers developed. It is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between reactive foam and gel surfaces and reactive gel surfaces. Evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias, and once for imprecision due to the low event rate.

The included study did not report data on time to pressure ulcer incidence.

None reported.

Using a split body comparison design, Hoshowsky 1994 compared reactive foam and gel surfaces with foam surfaces.

Hoshowsky 1994 (91 participants) reported this outcome but indicated that no pressure ulcers developed. It is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between reactive foam and gel surfaces and foam surfaces. Evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias, and twice for imprecision due to the small sample size and the low event rate.

The included study did not report data on time to pressure ulcer incidence.

None reported.

We report evidence from 20 RCTs on the e ects of many types of non-foam and non-air-filled reactive surfaces compared with other types of beds, mattresses or overlays, on the incidence of pressure ulcers in any population in any setting. These non-foam and nonair-filled reactive surfaces include: reactive water surfaces, reactive fibre surfaces, reactive gel surfaces, reactive foam and gel surfaces, reactive sheepskin surfaces, and three types of reactive surfaces that could not be defined using the NPIAP S3I terms: Bedcare Sense Textile multilayer mattress system (Van Leen 2018), microfluid static overlays (Vermette 2012), and Aiartex mattress overlays (Cassino 2013a; Ricci 2013). We did not analyse data reported in the 11 studies using intervention or control surfaces that could not be classified. For comparisons with available data, almost all evidence was uncertain in terms of e ects on ulcer incidence or any other outcome such as patient comfort or adverse events. There is only low-certainty evidence that reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds may Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( Cochrane Database of Systematic Reviews increase the proportion of people developing a new pressure ulcer compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds.

As detailed in Search methods for identification of studies, we ran a comprehensive set of literature searches to maximise the relevant research included here.

Whilst the current pressure ulcer guidelines o en recommend using an air-filled or foam surface for people at risk for developing pressure ulcers (NICE 2014; EPUAP/NPIAP/PPPIA 2019), we found a range of non-foam and non-air-filled reactive surfaces had been evaluated. These included reactive water surfaces, reactive fibre surfaces, reactive gel surfaces, reactive foam and gel surfaces, and reactive sheepskin surfaces.

Current guidelines seldom limit the appropriateness of any specific support surfaces to adults or children. All participants in included studies were adults (with the reported average age ranging from 37.2 to 85.4 years, median of 72.5 years). Across the included studies, more than half (57.0%) of enrolled participants were female. Almost all of the enrolled participants (4040/4653; 86.8%) were at (high) risk of pressure ulceration, with risk assessed using a risk assessment tool (e.g. the Braden scale), and most of the 3087 participants (76.4%) were ulcer-free at the time of being recruited. Three included studies (with 953 participants) did include participants with superficial pressure ulcers at baseline.

Most of the included studies were small (half had fewer than 198 participants) whilst nine studies enrolled more than 200 participants. These nine studies together accounted for 80.3% (3737/4653) of the participants in this review.

The geographical scope of included studies was limited. Almost all the studies were from high-income and upper-middle-income economies -mostly from Europe and North America -and one study was from Iran (IRCT2015110619919N3).

Included studies recruited participants from a variety of care settings including: acute care settings (10 studies); community and long-term care settings (seven studies), operating rooms (two studies), and intensive care units (one study). Two of the 12 comparisons included studies from a variety of care settings (reactive water surfaces versus alternating pressure (active) air surfaces, and reactive fibre surfaces versus alternating pressure (active) air surfaces). However, due to a limited number of included studies for most comparisons, we could not perform pre-specified subgroup analysis by di erent care settings. Thus, for these two comparisons, we are unable to draw conclusions about potential modification of treatment e ects in di erent care settings. The remaining 10 comparisons included data that were only from either intensive care units, nursing home settings, acute care settings or operating rooms, and almost all of these 10 comparisons only included one study. Therefore, their evidence is very limited.

We note that some non-foam and non-air-filled surfaces might not be clinically appropriate for some people who need a support surface (e.g. sheepskin surfaces). There was no analysable data for some comparisons, including the comparison involving reactive sheepskin surfaces. Further planned review work using network meta-analysis might add to the findings reported here.

Another limitation in the included studies was the large variation in terms of follow-up durations (with a range from seven days to six months, median of four weeks -longer than the median of 14 days' follow-up in other related reviews). This is partly because di erent follow-up durations are appropriate in di erent care settings. For example, participants staying at acute care settings are more likely to be discharged a er a short-term hospital stay whilst those staying at community and long-term care settings can have longterm follow-up. We note that, for most comparisons in this review, the median duration of follow-up for the pressure ulcer incidence outcome is shorter than the overall median of four weeks. The short median duration of follow-up may contribute to an underestimation of pressure ulcer incidence across study groups of the included studies because most pressure ulcers would occur in the first two to four weeks a er hospital admission (Schoonhoven 2007), and some incident pressure ulcers may have been missed in these studies.

We implemented the GRADE approach for assessing the certainty of the evidence and found that most included evidence from our 12 meta-analyses or syntheses across 10 comparisons was of very low certainty and only one piece of evidence was of low certainty. Downgrading of evidence was largely due to the unclear or high risk of bias of findings, and imprecision due to the small numbers of participants, events, wide confidence interval that failed to exclude important benefits or harms, or all of these. There was also some indirectness for one comparison.

We did not assess the certainty of the evidence for two comparisons: reactive water surfaces versus foam surfaces and reactive water surfaces versus reactive fibre surfaces. This is because the studies included in these two comparisons could not contribute to any synthesis.

We downgraded once or twice for study limitations for all of the 12 analyses. We assessed risk of bias according to seven domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, selective outcome reporting, incomplete follow-up, and other potential biases. Of the 20 studies, we judged four as being at unclear overall risk of bias, and 16 at high overall risk of bias. The prevalence of high overall risk of bias is partly due to the non-blinding of participants and personnel for most of the comparisons. We acknowledged that such blinding of participants and personnel is impractical for most comparisons. Therefore, we did not downgrade the certainty of evidence for studies at high overall risk of bias solely due to the possible presence of performance bias.

Nine studies were also at high risk of bias due to unblinded outcome assessment. Unblinded assessment has been found to exaggerate odds ratios (from subjective binary outcomes) by, on average, 36% (Hróbjartsson 2012). The outcome assessment of pressure ulcer incidence is subjective and blinded assessment, whilst operationally challenging, can be undertaken (for example, through masked adjudication of photographs of pressure areas (Baumgarten 2009)). Therefore, we considered unblinded pressure ulcer incidence assessment could substantially bias e ect Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( Cochrane Database of Systematic Reviews estimates in the included studies and downgraded the certainty of evidence for detection bias on a study-by-study basis.

We downgraded once for indirectness for the support-surfaceassociated patient comfort outcome in the comparison of reactive fibre surfaces versus alternating pressure (active) air surfaces. This was because we considered that the comfort outcome measure used in the only study (dropouts due to the discomfort of using the support surfaces) was an indirect measure of the comfort outcome for this review.

Statistical heterogeneity was low for all of the evidence syntheses we performed and we did not downgrade for inconsistency for this evidence. The low statistical heterogeneity was partly because all these syntheses included no more than four studies and nine of the 12 syntheses included only one study.

We have to note that although we planned to calculate prediction intervals to understand the implications of heterogeneity, all analyses included a small number (up to four) of included studies which was fewer than the 10 needed for this calculation.

We downgraded once or twice for imprecision for all of the 12 evidence syntheses. Study sample sizes were small in most cases (median sample size: 192.5) with o en small numbers of events and wide associated confidence intervals around e ect estimates. Confidence intervals o en crossed the line of null e ect or RRs = 0.75 and 1.25, or both, thus meaning we could not discern whether the true population e ect was likely to be beneficial or harmful.

We did not downgrade the certainty of evidence for publication bias in all meta-analyses. This is because (1) we have confidence in the comprehensiveness of our literature searches; and (2) we did not find any clear evidence of non-reporting bias of study results. Although we planned to perform funnel plots for meta-analysis to visually inspect publication bias, there was no analysis including more than ten studies.

We followed pre-specified methods to review evidence in order to prevent potential bias in the review process. For example, we ran comprehensive electronic searches, searched trials registries, and checked references of systematic reviews identified in electronic searches.

This review also has limitations. Firstly, some included studies may have considered co-interventions as 'usual care' but did not fully describe them. We assumed that all studies had provided co-interventions equally to participants in their study groups if there was nothing to indicate that this was not the case. Secondly, we did not implement pre-specified subgroup analysis as we mentioned above, mainly because no analysis included more than ten studies. Thirdly, of the 11 studies with surfaces that could not be classified, seven used controls that were described as 'standard hospital surfaces' but did not specify construction materials of these surfaces. Although we made e orts to collect information on these surfaces, we were not able to classify them. Traditionally, 'standard hospital surfaces' meant foam surfaces, but we felt adopting that assumption was unwarranted. Accurate classification of these surfaces in the future could add evidencefor example, on reactive sheepskin surfaces -to this review. Finally, we were not able to pre-specify the comparisons included in this review. This is because specific support surfaces applied could only be known and defined once eligible studies were included. However, we pre-planned to use the NPIAP S3I 2007 support surface terms and definitions to define specific support surfaces in order to avoid any potential bias.

To our knowledge, among the 14 systematic reviews or metaanalyses we identified in electronic searches of this review ( However, we considered their materials as undefined using the revised NPIAP S3I support surface terms and definitions. McInnes 2015 classified support surfaces into 'low-tech' and 'high-tech' groups in general and covered a range of reactive surfaces (the 'Silicore overlay', a 'water mattress', and a 'foam pad') ' using low-tech 'constant low-pressure devices'.

Shi 2018a grouped some interventions under the term 'standard hospital surfaces' but concluded that the types of surfaces labelled in this way varied over time, and by setting. We noted that the NPIAP S3I 2007 recommends specifying what 'standard hospital surfaces' are. In this review, we made great e orts to define surfaces where these surfaces were described as a 'standard hospital surface' in the included studies to ensure they were placed in the correct comparisons. We considered those 'standard hospital surfaces' that had no characteristic details and which we could not map to the NPIAP S3I 2007 classification as undefined surfaces.

These above re-definitions and re-classifications of specific support surfaces can explain some of the inconsistency between these reviews. For example, because 'standard hospital surfaces' were redefined as surfaces that could not be classified, we did not perform analysis for the relevant comparison involving reactive sheepskin surfaces. Additionally, Shi 2018a was a network meta-analysis.

Shi 2018a considered pressure ulcer incidence and supportsurface-associated patient comfort outcomes only, whilst this review added adverse e ect evidence to the evidence base.

Current NICE 2014 and EPUAP/NPIAP/PPPIA 2019 pressure ulcer guidelines primarily focus on foam and air-filled surfaces in their recommendations. We found evaluations for a range of non- Cochrane Database of Systematic Reviews foam and non-air-filled reactive surfaces. Comparative evidence is almost all uncertain about the relative e ects of these types of non-foam and non-air-filled reactive surfaces compared with alternatives explored in randomised controlled trials on ulcer incidence, health-related quality of life, adverse events and patient comfort. However, reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds may increase the risk of having new pressure ulcers compared with alternating pressure (active) air surfaces applied on both operating tables and hospital beds.

Given the large number of di erent support surfaces available, future studies should prioritise which support surfaces to evaluate on the basis of the priorities of decision-makers. For example, reactive gel surfaces versus foam surfaces or reactive air surfaces could be a high priority for further evaluation. All interventions used should be clearly described using the current classification system. Researchers should avoid use of terms such as 'standard hospital mattress' without further detail about the specific nature of the support surfaces being evaluated. Limitations in included studies are largely due to small sample size and sub-optimal RCT design. The incidence of pressure ulcers can be low in certain settings and this needs to be considered in sample size calculations and when considering the feasibility of trial conduct. Under-recruitment or over-estimation of event rates that then fail to occur, or both, can lead to imprecision and less robust e ect estimates.

Future studies should also consider carefully the choice of outcomes they report. Time-to-event data for pressure ulcer incidence should be used in studies. Careful and consistent assessment and reporting of adverse events needs to be undertaken to generate meaningful data that can be compared between studies. Likewise, patient comfort is an important outcome but poorly defined and reported, and this needs to be considered in future research studies. Further studies should aim to collect and report health-related quality of life using validated measures. Finally, future studies should nest cost-e ectiveness analysis in their conduct where possible.

Any future studies must be undertaken to the highest standards possible. Whilst it is challenging to avoid the risk of performance bias in trials of support surfaces as blinding of participants and personnel is seldom possible, stringent protocols -for example, in terms of encouraging consistent care and blinded decision-making -can help to minimise risk. It is also important to fully describe co-interventions (e.g. repositioning) and ensure protocols mandate balanced use of these across trial arms. The risk of detection bias can also be minimised with the use of digital photography and adjudicators of the photographs being masked to support surfaces (Baumgarten 2009). Follow-up periods should be for as long as possible and clinically relevant in di erent settings. Where possible and useful, data collection a er discharge from acute settings may be considered.

The authors are grateful to the following peer reviewers who provided feedback on both the protocol and the review: Julie Bruce and Zena Moore. Thanks are also due to Jessica Sharp for copyediting the protocol of this review, to Denise Mitchell for additional copy-edit feedback, to Faith Armitage for copy-editing the review and to Nicole Pitcher for writing the Plain Language Summary.

We also would like to thank Asmara Jammali-Blasi for screening search records; and to thank Zhenmi Liu, Gill Norman, and Melanie Stephens for double-checking data extraction and risk of bias assessment for this review. 

Shi C, Westby M, Norman G, Dumville J, Cullum N. Node-making processes in network meta-analysis of non-pharmacological interventions should be well planned and reported. Journal of Clinical Epidemiology 2018;101:124-5.

Shi C, Dumville JC, Cullum N. Skin status for predicting pressure ulcer development: a systematic review and meta-analyses. Cochrane Database of Systematic Reviews

• "opinions on mattresses" described as "the acceptability of the mattress" and rated as the numbers of sta satisfied and the numbers of patients satisfied with different mattresses

Random sequence generation (selection bias)

Unclear risk Quote: "Six hundred patients at risk for pressure sores were randomised in either a control group or one of two experimental groups ... They were allotted to one of the three groups ..."

Comment: method of randomisation was not reported.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "One of us [note: study's authors] assessed the condition of the skin ..."

Comment: appears to have no blinding, and the pressure ulcer incidence outcome measurement is likely to be influenced by lack of blinding.

Incomplete outcome data (attrition bias) All outcomes

Quote: "Six hundred patients at risk for pressure sores were randomised ..."

Quote: "Among the 600 risk-patients ... 118 dropped out during the first 24 hours before the first dermatologic inspection. This did not impair randomization."

Quote: "The groups remained comparable throughout the 10-day study period"

Comment: unclear risk of bias was judged because authors claimed that randomisation was not impaired though the proportion of missing data was high and no reasons for missing data were provided.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: "... to determine the efficacy and safety of the experimental system (study group), in comparison with conventional management (control group), for the prevention of pressure ulcers in the operative and postoperative settings"

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( in the operating room on top of a standard operating room pad, and a Pressure Guard II hospital replacement mattress (Span-America Medical Systems, Inc., Spartanburg, SC) on the hospital bed" (Aronovitch 1999); for operating table, Action Pad (Action Products) consisting of AKTON® Viscoelastic polymer that looks and feels like a gel (www.actionproducts.com/media/files/Action_Sup-port_Surface_Brochure.pdf); a series of PressureGuard products identified from Span-America product catalogue (www.spanamerica.com/product-catalog-new.php) and the catalogue states "every PressureGuard model combines the effectiveness of an air flotation system with the unmatched stability and safety of a multi-component engineered foam shell" • NPIAP S3I classification: non-powered, reactive gel surface Outcomes that are not considered in this review but reported in trials:

• No further outcomes

Random sequence generation (selection bias) Unclear risk Quote: "Randomization was performed by week rather than by patient to decrease protocol error."

Comment: unclear risk of bias.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Comment: no information provided.

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( 

Blinding of outcome assessment (detection bias) All outcomes

Quote: "Patients were examined following surgery and daily for pressure ulcers, including number, stage (I-IV), size (area), location, and appearance."

Comment: insufficient information to permit judgement of low or high risk of bias.

Incomplete outcome data (attrition bias) All outcomes

Quote: "Seven patients (8.75%) in the control group developed a total of 11 pressure ulcers ..."

Comment: high risk of bias because 7 (8.75%) in control group implied 80 of 105 individuals were considered in data analysis, meaning a large proportion of missing data in the control group alone. However, the number of available cases in experimental group is not given.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to identify inexpensive and, if possible, non-mechanical constant low pressure overlays effective for patients at long-term risk in continuing-care wards for elderly people Study design: randomised controlled trial (a poorly designed multi-arm multi-stage trial, with re-randomisation)

Duration of follow-up: not given; assessment with a mean of 17.7 days Number of arms: 7 (the trial had a Vaperm as control arm but its participants were not randomised. Vaperm data were not extracted for this review)

Single centre or multi-sites: not specified Study start date and end date: not described 

• Not reported

• Not reported

Random sequence generation (selection bias) Low risk Quote: "the patient was randomly allocated to an experimental overlay by the researcher writing the names of all those available at the time on slips of paper which were folded and offered to the nurse to choose one blind" Library Trusted evidence. Informed decisions. Better health.

Allocation concealment (selection bias) High risk Quote: "the patient was randomly allocated to an experimental overlay by the researcher writing the names of all those available at the time on slips of paper which were folded and offered to the nurse to choose one blind. The designated overlay was then placed on the bed" Comment: high risk of bias because it appears difficult to conceal the allocation process as the authors. described. The nurse would have knowledge of which overlays were available at the time of consent.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided.

Incomplete outcome data (attrition bias) All outcomes

Unclear risk Comment: no information provided.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias High risk Comment: high risk of bias because some individuals may be repeatedly observed and included in analysis (i.e. correlation issue in analysis). For example, Bliss stated "there were no written criteria determining the decision to stop a trial [i.e. using an overlay as the experimental intervention]. This depended mainly on these experienced nurses' unwillingness to allow it to continue because of enlargement of an existing sore, a new blister, discolouration, oedema ... Patients who developed pressure damage between assessments might also be taken o their overlay ... if they later improved ... they were re-randomized for another trial period [i.e. comparisons of new overlays]". Additionally, overlays were observed for unequal periods of time. Treatments were discontinued or introduced without pre-specified stopping rules. Some comparisons are not parallel.

Methods Study objective: to evaluate the performance and effectiveness of an anti-bedsore, three-dimensional overlay (Aiartex®, Herniamesh) compared with a commonly-used gel overlay (Akton® Overlay) All reported adverse events using allocated support surfaces

• Notes: 10 deaths occurred in the 72 patients enrolled, 3 of which occurred in the three-dimensional overlay study group and 7 in the gel overlay group.

• Reporting: not reported

• Reporting: not reported

Outcomes that are not considered in this review but reported in trials:

• Ulcer healing: 8 cases (11.1%) healed, including 3 cases in the three-dimensional overlay group and 5 in the gel overlay group

Random sequence generation (selection bias) Unclear risk Quote: "Assignment to one aid or the other was randomised using closed envelopes which were opened at the moment of assignment. In the randomization lists the two aids were balanced at a ratio of 1:1."

Comment: unclear risk of bias because the method of generating random sequence unspecified.

Unclear risk Quote: "Assignment to one aid or the other was randomised using closed envelopes which were opened at the moment of assignment. In the randomization lists the two aids were balanced at a ratio of 1:1."

Comment: unclear risk of bias because the method of concealing allocation unspecified.

Blinding of participants and personnel (performance bias) All outcomes

Quote: "Open randomised multicenter study ..."

Blinding of outcome assessment (detection bias) All outcomes

Quote: "Open randomised multicenter study ..."

Incomplete outcome data (attrition bias) All outcomes

Comment: it appears to include all patients in analysis. 

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to determine the efficacy of the alternating air mattress overlay and the silicone mattress overlay in preventing pressure ulcers Study design: sequential randomised controlled trial

Single centre or multi-sites: single centre

Setting: extended care facility for neurological conditions Participants

Inclusion criteria: patients in extended care facility for neurological conditions; 18 to 55 years old; with no evidence of skin breakdown for at least 2 weeks prior to the study; and who were at high risk of developing ulcers according to the Norton's Scale (i.e. less than a score of 14). 

Silicore mattress overlay • Description of interventions: "... composed of siliconized hollow fibers covered in waterproofed cotton" placed over a standard hospital spring mattress or a 10 cm foam mattress and supported by standard hospital bed frames • NPIAP S3I classification: non-powered, reactive fibre-filled surface • Co-interventions: usual care (including turning every 2 or 3 h) • Number of participants randomised: n = 94 • Number of participants analysed: n = 76

Proportion of participants developing a new pressure ulcer

• Outcome type: binary • Time points: 3 months • Reporting: fully reported • Measurement method (e.g. scale, self-reporting): measured using the Exton-Smith scale (0 = none; 1 = persistent erythema in an irregular ill-defined area; 2 = localised blister with distinct edges indicating early pigmentation with heat and induration; 3 = superficial sore extending into the subcutaneous fat with irregular rolled skin edges, dark pigmentation and a drainage; 4 = deep sore extending into deep fascia in which bone can be identified at the base of ulceration, with profuse drainage and necrosis; 5 = gangrenous sore with profuse multiple drainages, extensive necrosis, and resultant osteomyelitis and septic arthritis) • Definition (including ulcer stage): the first appearance of any ulcers (scores of Grade 1 or above defined using Exton-Smith scale) • Dropouts: 21 missing data (including 2 death, 19 discomfort, 0 transferred) in alternating air mattress overlay; 18 (including 0 death, 17 discomfort, 1 transferred) in Silicore overlay • Notes (e.g. other results reported): 39 individuals (with ulcers of any stages) in alternating air mattress; 45 individuals (with ulcers of any stages) in Silicore. Numbers of ulcers by grade reported also, but not extracted.

• Reporting: not reported

• Reporting: partially reported • Measurement method (e.g. scale, self-reporting): not described • Definition: discomfort as a reason for dropout • Dropouts: not described • Notes: 19 of 93 in alternating air mattress; 17 of 94 in Silicore.

• Reporting: not reported

• Reporting: not reported

• Notes: total overall cost per year's use presented in cost analysis paper by overlay groups: USD 771 in air overlay group and USD 500 in silicone overlay group

Outcomes that are not considered in this review but reported in trials:

• Healing duration of ulcers • Severity of new ulcers • Acceptability measured for 40 patients in total (20 from each group) Cochrane Database of Systematic Reviews

Random sequence generation (selection bias) Unclear risk Quote: "A modified sequential clinical trial ... was used to assign subjects randomly to one of the two mattresses in groups of 20"

Comment: the method of randomisation was not reported.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Comment: no information provided but understandably difficult to blind participants and personnel.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "The research assistant ... was responsible for the assessment of all outcome measures. She ... was not informed about the study"

Comment: low risk of bias because blinding is likely applied.

Incomplete outcome data (attrition bias) All outcomes

Quote: "Thirty-nine subjects did not complete the trial for reasons shown in Table 1 "

Comment: high risk of bias because over 20% of 187 randomised individuals missed and most of the dropouts were due to discomfort.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to assess 2 commonly used special mattresses in a randomised trial involving adult non-geriatric chronic neurologic patients 

Setting: long-term care hospital for chronic neurologic conditions Participants

Inclusion criteria: consenting patients in a long-term care hospital for chronic neurologic conditions ... a) between 19 and 60 years of age, b) free of any evidence of skin breakdown two weeks prior to the study, and c) considered to be at high risk of developing pressure ulcers based on assessments conducted by the ward team [Norton scale score of 14 or less; and clinical judgement] Outcomes that are not considered in this review but reported in trials:

• Equipment condition

Random sequence generation (selection bias) Unclear risk Quote: "All were randomly assigned to one of the two types of mattresses"

Comment: the method of randomisation was not described.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "one of the investigators (DD) conducted weekly skin checks of the subjects"

Comment: high risk of bias for pressure ulcer incidence outcome because it is unlikely that the investigator who assessed skin conditions was blinded.

Incomplete outcome data (attrition bias) All outcomes

Quote: "Thirty-two patients met the criteria for this study ... all admitted to the trial and completed it"

Daechsel 1985 (Continued) Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( Cochrane Database of Systematic Reviews Comment: no missing data.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: not described Outcomes that are not considered in this review but reported in trials:

• None

Ewing 1964 (Continued) Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( 

Random sequence generation (selection bias)

Unclear risk Quote: "The patients were ... allotted to a treated or a control group by random selection"

Comment: the method of randomisation was not described.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided.

Incomplete outcome data (attrition bias) All outcomes

Unclear risk Comment: no information provided.

Selective reporting (reporting bias)

Unclear risk Comment: no information provided.

Other bias Unclear risk Comment: no information provided.

Study objective: to examine the effects of 2 OR table mattresses and 1 mattress overlay on intraoperative pressure sore formation Outcomes that are not considered in this review but reported in trials:

• None

Random sequence generation (selection bias)

Unclear risk Comment: unclear risk of bias because each patient served as their own control but within the patient, the allocation of interventions was unspecified.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Quote: "Use of the overlay in this manner prevented the investigators from being blinded at the time of postoperative assessment whenever the overlay was used."

Comment: high risk of bias because unblinding is clearly stated.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "Use of the overlay in this manner prevented the investigators from being blinded at the time of postoperative assessment whenever the overlay was used."

Comment: high risk of bias because unblinding is clearly stated.

Incomplete outcome data (attrition bias) All outcomes

Unclear risk Comment: no information provided.

Selective reporting (reporting bias)

Unclear risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes. No data are reported on the number or rate of pressure ulcers by group and this would be expected. Only statistically significant odds were reported.

Trusted evidence. Informed decisions. Better health.

Other bias High risk Comment: the study appears to consider parts of a person's body as unit of analysis. However, the logistic regression as described does not appear to take into account the multiple measures per person.

Methods Study objective: to investigate the effectiveness of a silicon protective pad on pressure ulcers among patients undergoing coronary artery bypass gra (CABG) surgery 

• Not reported

• Not reported

Random sequence generation (selection bias) Unclear risk Quote: "... 164 patients with coronary artery diseases and candidate for CABG surgery were randomly assigned ..."

Comment: unclear risk of bias because the sequence generation process is not specified in this abstract.

Unclear risk Comment: no information provided in this abstract.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided in this abstract.

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided in this abstract.

Trusted evidence. Informed decisions. Better health.

Incomplete outcome data (attrition bias) All outcomes

Unclear risk Comment: no information provided in this abstract.

Selective reporting (reporting bias)

Unclear risk Comment: no information provided in this abstract.

Other bias Unclear risk Comment: no information provided in this abstract.

Methods Cochrane Database of Systematic Reviews covered by the sheepskin were protected with a second sheepskin or specific sheepskin elbow and heel protectors. • NPIAP S3I classification: non-powered, reactive sheepskin surface • Co-interventions: usual nursing care, including repositioning, as determined by ward sta 

• Outcome type: binary • Time points: not specified • Reporting: partially reported • Measurement method (e.g. scale, self-reporting): this is measured as an adverse event • Definition: not reported • Dropouts: not reported • Notes: 10 patients in the sheepskin group complained about its comfort ("too hot", 6; sensitive to the wool surface, 2; "uncomfortable", 2) and requested its removal.

• Reporting: partially reported; see above

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( 

Health-related quality of life (HRQOL)

• Reporting: not reported

• Reporting: not reported

Random sequence generation (selection bias) Low risk Quote: "patients were randomly allocated to receive either the sheepskin or standard treatment, using numbered cards in individually sealed opaque envelopes; blocks of 16 envelopes (eight of each group) were shuffled before use"

Comment: low risk of bias because investigators describe shuffled envelope method of randomisation.

Allocation concealment (selection bias) Low risk Quote: "patients were randomly allocated to receive either the sheepskin or standard treatment, using numbered cards in individually sealed opaque envelopes; blocks of 16 envelopes (eight of each group) were shuffled before use"

Comment: low risk of bias because researchers could not foresee next assignment because serially numbered, sealed opaque envelopes were used.

Blinding of participants and personnel (performance bias) All outcomes

Quote: "As it was logistically impossible to blind patients, ward sta and research nurses to the treatment group, this was an open label, unblinded trial" Comment: high risk of bias because clearly reported that there was no blinding.

Blinding of outcome assessment (detection bias) All outcomes High risk Outcome group: primary outcome Quote: "As it was logistically impossible to blind patients, ward sta and research nurses to the treatment group ... Research nurses assessed each participant daily for pressure ulcer risk as described previously, and for skin integrity"

Comment: high risk of bias because clearly reported that there was no blinding.

Incomplete outcome data (attrition bias) All outcomes

Comment: high risk of bias because 52 of 270 and 46 of 269 who were randomised were excluded from data analysis and of these exclusions 9 had pressure ulcers on day 1.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Trusted evidence. Informed decisions. Better health.

Methods Study objective: to compare the effectiveness of 2 pressure-reducing devices [an air-filled overlay and a gel mattress] in a group of elderly nursing home residents 

Interventions

SofCare overlay

• Description of interventions: air-filled overlay (SofCare overlay) Gaymar Industries. Additional source of information "Gaymar SofCare air mattress ... composed of three distinct layers of more than 300 compensating air cells. The cells are interconnected through a series of air channels. As the cells exchange air, the patient's weight is redistributed over the entire surface of the cushion ... SofCare is unlike any other inflated device ... SofCare looks as so as it feels, "customizing" itself to the body weight and configuration of each individual patient. By conforming to the patient ... (www.rehabmart.com/pdfs/gaymar_sof_care_overlay_brochure.pdf)" • NPIAP S3I classification: non-powered, reactive air surface • Co-interventions: not described • Number of participants randomised: not described Outcomes that are not considered in this review but reported in trials:

• No

Random sequence generation (selection bias) Low risk Quote: "Using a table of random numbers, each subjected was placed into ..."

Comment: low risk of bias because a proper randomisation was done.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes Library Trusted evidence. Informed decisions. Better health.

Quote: "Patients in both study groups were assessed by the same researcher for the presence of pressure ulcer development over areas of bony prominence"

Comment: unclear risk of bias because no information on blinding was reported.

Incomplete outcome data (attrition bias) All outcomes

Outcome group: primary outcome Quote: "... the initial study population was 76 subjects ..."

Quote: "A total of 74 subjects were in the study ... Two subjects were excluded from the study ... Those subjects who participated in the study for four to six months were included in the data analysis. Eighteen residents developed pressure ulcers during the course of the study, nine residents had preexisting pressure ulcers, and 36 residents did not develop a pressure ulcer"

Comment: unclear risk of bias because the patient flow is insufficiently clear and the proportion of missing data is probably between 10/74 (13.5%) and 13/74 (17.6%).

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Study objective: to estimate the relative incidence of hospital-acquired pressure ulcers among elderly orthopaedic patients nursed on a standard hospital mattress plus an Australian Medical Sheepskin overlay, compared to those nursed on either a standard mattress alone or a standard mattress with other low technology constant pressure supports. Exclusion criteria: no risk (requiring no intervention) or high risk (requiring more complex interventions) for developing pressure ulcers; patients with a pre-existing pressure ulcer; non-English speaking patients (unless an interpreter was available); patients with an anticipated stay of less than 48 hours; coloured skin patients where stage 1 ulcer detection is difficult Cochrane Database of Systematic Reviews

• Time points: not described • Reporting: partially reported • Measurement method (e.g. scale, self-reporting): rating the comfort of the bed surface on a 10 point scale where 1 indicated "very uncomfortable" and 10 "very comfortable"; withdrawal due to discomfort • Definition: not described • Dropouts: a total of 268 patients (124 control and 144 experimental) completed the rating scale • Notes: patients in the experimental group rated comfort significantly higher than the control group (Mann-Whitney U, Z = -7.74, P < 0.0001)

All reported adverse events using allocated support surfaces

• Outcome type: binary • Time points: not described • Reporting: partially reported • Measurement method (e.g. scale, self-reporting): not described • Definition: not described • Dropouts: not described • Notes: "Six patients in the experimental group withdrew before completion of data collection because the sheepskin caused an irritation, was too hot or uncomfortable"

• Reporting: not reported

• Reporting: not reported

Outcomes that are not considered in this review but reported in trials:

• No

Random sequence generation (selection bias) Unclear risk Quote: "patients were randomly allocated (using sealed envelopes) by research nurses to receive one of two interventions"

Comment: unclear risk of bias because random sequence generation method unclear.

Allocation concealment (selection bias) Unclear risk Quote: "patients were randomly allocated (using sealed envelopes) by research nurses to receive one of two interventions"

Comment: unclear risk of bias because the method of concealing allocation is not specified.

Blinding of participants and personnel (performance bias) All outcomes

Quote: "Blinded outcome assessments were not possible because the support surfaces could not be disguised and patients could not be moved o the bed for assessment of their pressure ulcers" Library Trusted evidence. Informed decisions. Better health.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "Blinded outcome assessments were not possible because the support surfaces could not be disguised and patients could not be moved o the bed for assessment of their pressure ulcers"

Comment: high risk of bias because it is clearly stated.

Incomplete outcome data (attrition bias) All outcomes

Quote: "data collected for patients up until the time of withdrawal has been included in the analysis with the exception of five controls and two patients from the experimental group for whom study participation time was not available"

Quote: "A total of 268 patients (124 control and 144 experimental) were able to complete the rating scale on the level of comfort of the bed surface."

Comment: low risk of bias because ITT analysis was conducted for pressure ulcer outcome and low rate of missing data for comfort outcome.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Study objective: to investigate the effectiveness of the Australian Medical Sheepskin (AMS) in the prevention of sacral pressure ulcers in somatic nursing home patients 

Baseline skin status: 47% with Braden score ≤ 18 in both sheepskin (n = 295) and usual care (n = 293) groups; no pre-existing ulcer Cochrane Database of Systematic Reviews described in Tierney 2007. The mean number of days with a sacral pressure ulcer in the first 30 days after admission: 10.7 days in usual care group vs. 9.2 in sheepskin group; t test, P = 0.46 (97% pressure ulcer-free days in sheepskin group vs. 94% in usual care group P < 0.001).

• Outcome type: binary • Time points: 30 days • Reporting: partially reported • Measurement method (e.g. scale, self-reporting): patients self-reported using a self developed 7item questionnaire with a 5-point rating answer structure (Items on softness, itching, smell, warmth, tickling, comfort, and if they would recommend an AMS to other patients) • Definition: comfort of the sheepskin as experienced by the patients • Notes: only patients using sheepskin answered the questionnaire; data not extracted All reported adverse events using allocated support surfaces • Definition: quality of life measured at day 30 by a visual analogue scale with two anchors: 0 = the worst health status ever and 100 = the best health status that could be imagined • Dropouts: 24 in sheepskin and 21 in usual care • Notes: QoL for patients with ulcers: mean 62.1 in sheepskin group vs. 61.3 in usual care group; Student's t-test P = 0.71.

• Reporting: not reported

Outcomes that are not considered in this review but reported in trials:

• Ease of use of the sheepskin as experienced by the care personnel

Random sequence generation (selection bias) Low risk Quote: "To ensure concealment of allocation, a randomization scheme was created in SPSS by assigning the intervention to a random sample of circa 50% in a list of 1,500 numbers and assigning the control group to the rest" Comment: low risk of bias due to the use of a proper randomisation method (computer randomisation).

Low risk Quote: "To ensure concealment of allocation, a randomization scheme was created in SPSS by assigning the intervention to ... This allocation of the group (sheepskin, usual care) was then blinded on a paper list numbered 1 through 1,500 by a secretary not further involved in the project ... the admitting nurse called the principal investigator who then disclosed the allocation from that blinded list to the nurse and she, in turn, to the patient"

Mistiaen 2010 (Continued) Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( Cochrane Database of Systematic Reviews Comment: low risk of bias due to the use of a proper method to conceal the allocation.

Blinding of participants and personnel (performance bias) All outcomes

Quote: "it is impossible to blind health professionals or patients to whether someone is in the experimental group or not, only the patient allocation itself was blinded to all parties involved"

Comment: high risk of bias since it was clearly reported there was no blinding.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "it is impossible to blind health professionals or patients to whether someone is in the experimental group or not, only the patient allocation itself was blinded to all parties involved ... assessed daily by the nurse caring for that patient that day"

Comment: high risk of bias since it was clearly reported there was no blinding.

Incomplete outcome data (attrition bias) All outcomes

Quote: "According to the intention-to-treat principle, all patients were analyzed in the groups they were randomised to"

Comment: low risk of bias because low rates of missing data in both groups (ITT analysis is claimed but is not actually done).

Selective reporting (reporting bias)

Low risk Comment: the study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to compare the postoperative pressure sore incidence in patients positioned on the standard operating table mattress with those positioned on the dry visco-elastic polymer pad Library Trusted evidence. Informed decisions. Better health.

Exclusion criteria: liver, urology and breast surgery; pressure damage of Grade 1a or above observed preoperatively; ward sta provision of preoperative alternating pressure mattress; dark skin pigmentation which precludes reliable identification of Grade 0 and Grade 1a skin assessments; skin conditions over the sacrum, buttocks or heels which preclude reliable identification of Grade 0 and Grade 1a skin assessments 

Random sequence generation (selection bias) Low risk Quote: "a telephone randomisation schedule was developed within random permuted blocks of 6, with a run-in of 8"

Comment: low risk of bias because study likely used a proper randomisation method.

Allocation concealment (selection bias) Low risk Quote: "a telephone randomisation schedule was developed, and managed by the Northern and Yorkshire Clinical Trials and Research Unit"

Comment: low risk of bias because study likely concealed allocation.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "All pre and intra-operative data were recorded by the research nurse, and post-operative data recorded by recovery and ward sta who were blind to the intraoperative mattress allocation. The record pertaining to the intra-operative randomised mattress allocation remained separate from the main data collection proforma to maintain the blind" Comment: unclear risk of bias because there is attempt to blind outcome assessment.

Incomplete outcome data (attrition bias) All outcomes

Comment: low risk of bias because although intention-to-treat (ITT) analyses claimed by authors, low proportions of missing data (17 of 222 vs 13 of 224) occurred in analysis.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias. Inclusion criteria: patients of both genders aged 65 years old or more, who had an anticipated hospitalisation period in the same unit lasting at least 28 days after assignment to the study groups; Braden score > 8 to < 14; Norton score > 6 to < 12; patients with pressure sores stage 1 eligible Exclusion criteria: those with ulcers of stage 2 or above; terminal or severely compromising illness, AIDS or hepatitis C; ongoing systemic corticosteroid therapy, immuno-suppressant therapy or chemotherapy; enrolment within the past 3 months in any study related to wound healing; allergy to mattress overlay components Health-related quality of life (HRQOL)

• Reporting: not reported

• Reporting: not reported

Outcomes that are not considered in this review but reported in trials:

• Global safety and tolerability of support surfaces.

Notes info@herniamesh.it and the contact author were contacted to clarify Aiartex but they did not add useful information.

Trusted evidence. Informed decisions. Better health.

Random sequence generation (selection bias) Low risk Quote: "Patients were randomised according to a computer generated pre-defined assignment list in sealed envelopes to use a standard mattress plus either three-dimensional or viscoelastic overlay"

Comment: low risk of bias due to the use of a proper randomisation method.

Unclear risk Quote: "Patients were randomised according to a computer generated pre-defined assignment list in sealed envelopes ..."

Comment: unclear risk of bias because it is unclear if envelopes are opaque.

Blinding of participants and personnel (performance bias) All outcomes

Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Quote: "Patient's conditions (any presence of skin lesions, pressure ulcers, erythema, area of skin maceration) were then re-assessed at days 7, 14, 21, and day 28 (the last visit)"

Quote: "The occurrence of any adverse event or allergic reaction was evaluated at each visit" Comment: no information provided.

Incomplete outcome data (attrition bias) All outcomes

Comment: low risk of bias because no missing data.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to determine the efficacy and safety of a multi-cell pulsating dynamic mattress system in comparison with conventional management for the prevention of pressure ulcers in the operative and postoperative period in patients having cardiovascular surgery approximately half of all patients in each group reported adverse events, with no differences between groups reported. All adverse events were related to the patient's condition; none were related to the multi-cell pulsating dynamic mattress system or conventional management support system.

• Reporting: not reported

• Reporting: not reported

Random sequence generation (selection bias) Unclear risk Quote: "Before surgery, patients were randomly assigned to either the multi-cell pulsating dynamic mattress system or conventional management. Randomization was done blindly by using a sealed opaque envelope that contained the randomization information (i.e. multi-cell pulsating dynamic mattress system vs. conventional management)"

Comment: unclear risk of bias because randomisation method is not described.

Unclear risk Quote: "Randomization was done blindly by using a sealed opaque envelope that contained the randomization information (i.e. multi-cell pulsating dynamic mattress system vs. conventional management)"

Comment: unclear risk of bias because randomisation method is not described.

Blinding of participants and personnel (performance bias) All outcomes

Comment: high risk of bias because it is unlikely that participants were blinded though no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Russell 2000 (Continued) Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers ( Cochrane Database of Systematic Reviews Quote: "Patients were examined immediately post-surgery for pressure ulcers, including number, stage (I to IV), size (area), location, and appearance. Patients were assessed daily for ... presence of pressure ulcers. A skin risk assessment was performed on days 1, 4, and 7 and on other days if a change in status was noted. Adverse events and concomitant medications were recorded daily"

Comment: unclear risk of bias because information on outcome assessment is insufficient for a proper judgement.

Incomplete outcome data (attrition bias) All outcomes

Quote: "Baseline characteristics and safety were evaluated for all randomised patients (i.e. intent-to-treat sample) ... The intent-to-treat sample included all patients who signed consent forms and who were placed either on a multi-cell pulsating dynamic mattress system or on a conventional mattress and had at least 1 day of observation post-surgery .

.. An evaluable sample of patients was defined as patients who signed consent forms, had a surgery length of at least 3 hours, and had a minimum of 3 days of observation post-surgery ... One analysis included the intent-to-treat sample (multi-cell pulsating dynamic mattress system, n = 89; conventional management, n = 96)"

Comment: low risk of bias because of the use of intention-to-treat (ITT) analysis.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Methods Study objective: to compare the pressure-reducing properties of 3 types of mattress overlays (water, alternating air and static air mattress surfaces) as used with bed-bound patients in a clinical setting Outcomes that are not considered in this review but reported in trials:

• No

Random sequence generation (selection bias) Unclear risk Quote: "patients for the first two groups were selected by lottery, and thereafter patients were allocated to each group systematically, in rotation" Comment: unclear risk of bias because it is unclear if a proper randomisation method was applied.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes

Unclear risk Comment: no information provided.

Incomplete outcome data (attrition bias) Cochrane Database of Systematic Reviews Comment: low risk of bias because of the use of a proper randomisation method.

Unclear risk Comment: no information provided.

Blinding of participants and personnel (performance bias) All outcomes

Unclear risk Comment: no information provided.

Blinding of outcome assessment (detection bias) All outcomes Unclear risk Quote: "Data were collected weekly, controlled by an independent research nurse."

Comment: unclear risk of bias because of the lack of sufficient information.

Incomplete outcome data (attrition bias) All outcomes Low risk Comment: low risk of bias because it appears to include all 206 patients in analysis.

Selective reporting (reporting bias)

High risk Comment: high risk of bias because the study protocol is available from https://www.trialregister.nl/trial/4435 and it is clear that the pre-specified costs outcome is not presented.

Other bias Low risk Comment: the study appears to be free of other sources of bias.

Study objective: to compare the efficacy of different surfaces in the prevention of pressure ulcers; to compare costs associated with the use of an inflated static overlay (ISO) with the standard treatment, which in the first author's facility consists of renting a microfluid static overlay (MSO) or a low-air-loss dynamic mattress (LALDM) with pulsation for moderate to very high-risk patients; to evaluate patient comfort Cochrane Database of Systematic Reviews Comment: intention-to-treat (ITT) analysis conducted.

Quote: "Of the 110 participants, 68 expressed opinions regarding comfort"

Comment: high risk of bias because 42 of 110 missed.

Selective reporting (reporting bias)

Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified.

Other bias Low risk Comment: the study appears to be free of other sources of bias. 

(1) Of the 74 participants randomised, the study authors did not specify the number of participants in each group. The review author assumed 37 participants in each group.

Overarching class of support surface (as used in this review)

Powered/non-powered reactive air surfaces A group of support surfaces constructed of air cells, which redistribute body weight over a maximum surface area (i.e. has reactive pressure redistribution mode), with or without the requirement for electrical power.

Static air mattress overlay, dry flotation mattress (e.g. Roho, Sofflex), static air mattress (e.g. EHOB), and static mode of Duo 2 mattress.

Trusted evidence. Informed decisions. Better health.

Powered/non-powered reactive lowair-loss air surfaces A group of support surfaces made of air cells, which have reactive pressure redistribution modes and a lowair-loss function, with or without the requirement for electrical power.

Low-air-loss hydrotherapy.

Powered reactive air-fluidised surfaces A group of support surfaces made of air cells, which have reactive pressure redistribution modes and an airfluidised function, with the requirement for electrical power.

Air-fluidised bed (e.g. Clinitron).

Non-powered reactive foam surfaces A group of support surfaces made of foam materials, which have a reactive pressure redistribution function, without the requirement for electrical power.

Convoluted foam overlay (or pad), elastic foam overlay (e.g. Aiartex, microfluid static overlay), polyether foam pad, foam mattress replacement (e.g. MAXIFLOAT), solid foam overlay, viscoelastic foam mattress/overlay (e.g. Tempur, CONFOR-Med, Akton, Thermo).

Non-powered reactive fibre surfaces A group of support surfaces made of fibre materials, which have a reactive pressure redistribution function, without the requirement for electrical power.

Silicore (e.g. Spenco) overlay/pad.

Non-powered reactive gel surfaces A group of support surfaces made of gel materials, which have a reactive pressure redistribution function, without the requirement for electrical power.

Gel mattress, gel pad used in operating theatre.

Non-powered reactive sheepskin surfaces A group of support surfaces made of sheepskin, which have a reactive pressure redistribution function, without the requirement for electrical power.

Australian Medical Sheepskins overlay.

Non-powered reactive water surfaces A group of support surfaces based on water, which has the capability of a reactive pressure redistribution function, without the requirement for electrical power.

Water mattress.

A group of support surfaces made of air cells, which mechanically alternate the pressure beneath the body to reduce the duration of the applied pressure (mainly via inflating and deflating to alternately change the contact area between support surfaces and the body; i.e. alternating pressure, or active, mode), with the requirement for electrical power.

Alternating pressure-relieving air mattress (e.g. Nimbus II, Cairwave, Airwave, MicroPulse), large-celled ripple.

Powered active low-air-loss air surfaces A group of support surfaces made of air cells, which have the capability of alternating pressure redistribution as well as low-air-loss for drying local skin, with the requirement for electrical power.

Alternating pressure lowair-loss air mattress.

Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews

A group of support surfaces made of air cells, which offer both reactive and active pressure redistribution modes, with the requirement for electrical power.

Foam mattress with dynamic and static modes (e.g. Softform Premier Active).

A group of support surfaces made of air cells, which offer both reactive and active pressure redistribution modes as well as a low-air-loss function, with the requirement for electrical power.

Stand-alone bed unit with alternating pressure, static modes and low-air-loss (e.g. TheraPulse).

A group of support surfaces made of any materials, used as-usual in a hospital and without reactive or active pressure redistribution capabilities, nor any other functions (e.g. low-air-loss, or air-fluidised). S24 TI decubitus or AB decubitus S23 TI ( bed sore* or bedsore* ) or AB ( bed sore* or bedsore* ) S22 TI ( pressure ulcer* or pressure sore* ) or AB ( pressure ulcer* or pressure sore* ) S21 (MH "Pressure Ulcer") S20 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 S19 TI net bed* or AB net bed* S18 TI ( kinetic therapy or kinetic table* ) or AB ( kinetic therapy or kinetic table* ) S17 TI ( turn* bed* or tilt* bed* ) or AB ( turn* frame* or tilt* frame* ) S16 TI sheepskin OR AB sheepskin S15 TI water suspension or AB water suspension S14 TI air bag* or AB air bag* S13 TI air suspension or AB air suspension S12 TI alternat* pressure or AB alternat* pressure S11 TI static air or AB static air S10 Cochrane Database of Systematic Reviews

Any one of the following.

• No blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding.

• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.

• Either participants or some key study personnel were not blinded, and the non-blinding of others is likely to introduce bias.

Any one of the following.

• Insu icient information to permit a judgement of low or high risk of bias.

• The study did not address this outcome.

Any one of the following.

• No blinding, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding.

• Blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.

Any one of the following.

• No blinding or incomplete blinding, and the outcome measurement is likely to be influenced by lack of blinding.

• Blinding of outcome assessment attempted, but likely that the blinding could have been broken.

Any one of the following.

• Insu icient information to permit a judgement of low or high risk of bias.

• The study did not address this outcome.

Any one of the following.

• No missing outcome data.

• Reasons for missing outcome data unlikely to be related to the true outcome (for survival data, censoring unlikely to be introducing bias).

• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.

• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk is not su icient to have a clinically relevant impact on the intervention e ect estimate. • For continuous outcome data, plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes is not su icient to have a clinically relevant impact on observed e ect size. • Missing data have been imputed using appropriate methods.

Any one of the following.

• Reason for missing outcome data is likely to be related to the true outcome, with either imbalance in numbers or reasons for missing data across intervention groups. • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk is su icient to induce clinically relevant bias in the intervention e ect estimate. • For continuous outcome data, the plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes is su icient to induce clinically relevant bias in the observed e ect size. • 'As-treated' analysis done, with substantial departure of the intervention received from that assigned at randomisation.

• Potentially inappropriate application of simple imputation.

Trusted evidence. Informed decisions. Better health.

Cochrane Database of Systematic Reviews (follow-up duration 4 and 12 weeks) new ulcers when using undefined surfaces; Ricci 2013 reported none of 25 participants in each study arm developed new ulcers. Support-surface-associated patient comfort (follow-up duration 12 weeks)

Ricci 2013 (50 participants) reported comfort that was measured by the study investigators using a non-validated 4-point scale (1 = poor, 2 = fair, 3 = good, 4 = excellent). They suggested no difference between reactive gel surfaces and undefined reactive surfaces in support surface associated patient comfort: Ricci 2013 reported 20 people using undefined reactive surfaces responded with 'good' and 5 with 'excellent'; and 24 people using reactive gel surfaces responded with 'good' and 1 with 'excellent'.

All reported adverse events (follow-up duration 12 weeks)

Ricci 2013 (50 participants) reported this outcome but indicated no adverse events.

Comparison: reactive sheepskin surfaces versus undefined 'standard hospital surfaces' Proportion of participants developing a new pressure ulcer (follow-up duration 30 days and six months or unspecified)

Three studies (1424 participants) reported data for this outcome (Jolley 2004; McGowan 2000; Mistiaen 2010) . These 3 studies all suggested that reactive sheepskin surfaces were associated with lower proportions of participants developing a new pressure ulcer than 'standard hospital surfaces'.

Time to pressure ulcer incidence (follow-up duration 30 days and six months or unspecified)

Three studies (1424 participants) reported this outcome (Jolley 2004; McGowan 2000; Mistiaen 2010) and these studies all suggested that the use of reactive sheepskin surfaces was associated with a lower hazard of having new ulcers than using standard hospital surfaces at any particular time up to 6 months. Support-surface-associated patient comfort (follow-up duration unspecified)

Only McGowan 2000 (297 participants) reported this outcome, measured using a 10-point scale (10 = "very comfortable"). McGowan 2000 reported that patients using reactive sheepskin surfaces rated comfort significantly higher than those using standard hospital surfaces (Z value of the Mann-Whitney U test = -7.74, P < 0.0001).

Health-related quality of life (follow-up duration 30 days)

Only Mistiaen 2010 (588 participants) reported this outcome, measured at 30 days using a 100point visual analogue scale (100 = the best health status that could be imagined). Mistiaen 2010 reported that the quality of life for those with ulcers using reactive sheepskin surfaces had a mean of 62.1 compared with 61.3 for those using standard hospital surfaces (Student's t-test P = 0.71).

Comparison: undefined surfaces compared with reactive air surfaces Proportion of participants developing a new pressure ulcer (follow-up duration 14 days) Vermette 2012 (110 participants) compared reactive air surfaces with alternating pressure (active) air surfaces or RIK® microfluid static overlay (MSO). Reported that 6 of 55 in MSO or low-air-loss dynamic mattress (LALDM); 2 of 55 in ISO (3.6%) using reactive air surfaces developed a new pressure ulcer and 6 of 55 (10.9%) people using undefined reactive surfaces developed new ulcers. The RR is 0.33 (95% CI 0.07 to 1.58). Support-surface-associated patient comfort (follow-up duration 14 days) Vermette 2012 (110 participants) compared reactive air surfaces with alternating pressure (active) air surfaces or RIK® microfluid static overlay; defined this outcome as participants self-rated comfort on a scale of 1 to 5 with 1 indicating very comfortable and 5 indicating not comfortable. In total, 68 participants rated comfort: 27 of 30 participants using undefined reactive surfaces and 29 of 34 using reactive air surfaces responded that they were comfortable or very comfortable.

Comparison: undefined surfaces compared with foam surfaces Proportion of participants developing a new pressure ulcer (follow-up duration minimum 5 days maximum 7 months) Van Leen 2018 (206 participants) compared foam surfaces with the Bedcare surface. Reported that 5 of 103 (4.9%) people using foam surfaces developed a new pressure ulcer and 9 of 103 (8.7%) people using undefined reactive surfaces developed new ulcers. The RR is 0.56 (95% CI 0.19 to 1.60).

All reported adverse events (follow-up duration 12 weeks) Van Leen 2018 (206 participants) compared foam surfaces with Bedcare surfaces. Reported this outcome but stated that there was no reported adverse events in either study group. It is uncertain if there is a difference in the adverse effects between foam surfaces and the undefined reactive sur- Cochrane Database of Systematic Reviews faces. Evidence certainty was very low, downgraded twice for high risk of bias in a domain other than performance bias, and once for imprecision, as the sample size was small and the number of events was relatively low. 

Chunhu Shi: conceived the review; designed the review; coordinated the review; extracted data; analysed or interpreted data; undertook quality assessment; performed statistical analysis; produced the first dra of the review; contributed to writing or editing the review; wrote to study authors/experts/companies; approved the final review prior to publication; is guarantor of the review.

Jo C Dumville: conceived the review; designed the review; coordinated the review; checked quality of data extraction; analysed or interpreted data; checked quality assessment; checked quality of statistical analysis; produced the first dra of the review; contributed to writing or editing the review; advised on the review; secured funding; performed previous work that was the foundation of the current review; approved the final review prior to publication.

+ -Cassino 2013a ? ? --+ + + Conine 1990 ? ? ? + -+ + Daechsel 1985 ? ? ? -+ + + Ewing 1964 ? ? ? ? ? ? ? Hoshowsky 1994 ? ? --? ? -IRCT2015110619919N3 ? ? ? ? ? ? ? Jolley 2004 + + ---+ + Lazzara 1991 + ? ? ? ? + + McGowan 2000 ? ? --+ + + Mistiaen 2010 + + --+ + + Nixon 1998 + + ? + + + + Ricci 2013 + ? ? ? + + + Russell 2000 ? ? -? + + + Sideranko 1992 ? ? ? ? + + + Stapleton 1986 ? ? ? ? ? ? ? Van Leen 2018 + ? ? ? + -+ Vermette

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

GRADE guidelines: 4. Rating the quality of evidencestudy limitations (risk of bias)

Development and preliminary testing of the new fivelevel version of EQ-5D (EQ-5D-5L)

Measuring inconsistency in meta-analyses

Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated

Cochrane Handbook for Systematic Reviews of Interventions version 6

Age (years): mean 67.9 (SD 11.1) in alternating air group

• NPIAP S3I classification: powered, alternating pressure (active) surface • Co-interventions: not described • Number of participants randomised

A 4-in. thick static air mattress, the Gaymar Sof Care bed cushion, manufactured by Gaymar Industries Inc., Orchard Park, NY" • NPIAP S3I classification: non-powered, reactive air surface • Co-interventions: not described • Number of participants randomised: n = 20 •

• NPIAP S3I classification: non-powered, reactive water surface • Co-interventions: not described • Number of participants randomised: n = 17 type: binary • Time points: not reported • Reporting: partially reported • Measurement method (e.g. scale, self-reporting): not reported • Definition (including ulcer stage): the number of patients developing pressure ulcers • Dropouts: not described; no missing assumed • Notes (e.g. other results reported): 5 of 20 in alternating air group; 1 of 20 in static air group

Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration

foam or transfoam):ti,ab,kw #4 overlay*:ti,ab,kw #5 "pad" or "pads":ti,ab,kw #6 "gel":ti,ab,kw #7 (pressure next relie*):ti,ab,kw #8 (pressure next reduc*):ti,ab,kw #9 (pressure next alleviat*):ti,ab,kw #10

Pressure Ulcer] explode all trees #24 (pressure next (ulcer* or sore* or injur*)):ti,ab,kw #25 (decubitus next (ulcer* or sore*)):ti

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers (Review)

Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration

Cochrane Database of Systematic Reviews #26 ((bed next sore*) or bedsore*):ti,ab,kw #27 {or

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers (Review)

Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration

Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers (Review)

Copyright © 2021 The Authors

• We changed the title of this review to 'Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers' whilst the title of the published protocol was 'Alternative reactive support surfaces (non-foam or air-filled) for preventing pressure ulcers

• Two review authors independently assessed the titles and abstracts of the new search results for relevance using Rayyan rather than using Covidence

• For new included studies, one review author independently extracted data and another review author checked all data, rather than two review authors carrying out independent data extraction

• When a study only had complete case data, we considered complete case data in the related main analysis (i.e. assuming no missing data issue)

• We presented separate 'Summary of findings' tables for six of the 12 comparisons evaluated in this review

• Where we did not pool data, we conducted a GRADE assessment and presented these assessments in a narrative format in 'Summary of findings' tables

This research was co-funded by the NIHR Manchester BRC. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.

Age (years): mean 77.7 (SD 10.6) in MSO or LALDM group, 77.9 (14.6) 

Baseline skin status: mean Braden 11.8 (SD 1.6) in MSO or LALDM group; 12.3 (1.3) in ISO group; at risk and no skin lesions Outcomes that are not considered in this review but reported in trials:• Costs

Random sequence generation (selection bias) Low risk Quote: "Participants were randomly assigned a rented surface (MSO or LALDM) or an ISO. Once subject consent was obtained and signed, the allocation sequence for mattress type was done by draw by the research nurse using an opaque envelope and the subject witnessing the draw"Comment: low risk of bias because it is likely a proper randomisation method was used.

Unclear risk Quote: "The allocation sequence was concealed from the research nurse enrolling and assessing the participants" Comment: unclear risk of bias because concealment approach is not specified.Blinding of participants and personnel (performance bias) All outcomes

Quote: "The purpose of this unblinded, randomised, prospective study ..."Quote: "Blinding was not obtained for the patient, the clinical sta , or the research evaluator because the surfaces were visible" Comment: high risk of bias because unblinding is clearly stated.Blinding of outcome assessment (detection bias) All outcomes

Quote: "The purpose of this unblinded, randomised, prospective study ..."Quote: "Blinding was not obtained for the patient, the clinical sta , or the research evaluator because the surfaces were visible" Comment: high risk of bias because unblinding is clearly stated.Incomplete outcome data (attrition bias) All outcomes

Quote: "Analyses were performed in intention-to-treat involving all 110 randomly assigned patients" Appendix 3. Risk of bias 1 'Risk of bias' assessment in individually randomised controlled trials

The study authors describe a random component in the sequence generation process, such as referring to a random number table, using a computer random number generator, coin tossing, shu ling cards or envelopes, throwing dice, drawing of lots.

The study authors describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example, sequence generated by odd or even date of birth, sequence generated by some rule based on date (or day) of admission, sequence generated by some rule based on hospital or clinic record number.

Insu icient information about the sequence generation process to permit judgement of low or high risk of bias.

Participants and study authors enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation); sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.

Participants or study authors enrolling participants could possibly foresee assignments and thus introduce selection bias, e.g. allocation was based on: using an open random allocation schedule (e.g. a list of random numbers); or assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered), alternation or rotation, date of birth, case record number, any other explicitly unconcealed procedure.

Insu icient information to permit a judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in su icient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.

Any one of the following.• No blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken. Any of the following.

• The study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way. • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon).

Any one of the following.• Not all of the study's pre-specified primary outcomes have been reported.• One or more primary outcomes are reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified. • One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse e ect). • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Insu icient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.

The study appears to be free of other sources of bias.

There is at least one important risk of bias. For example, the study:• had a potential source of bias related to the specific study design used; or • has been claimed to have been fraudulent; or • had some other problem.

There may be a risk of bias, but there is either:• insu icient information to assess whether an important risk of bias exists; or • insu icient rationale or evidence that an identified problem will introduce bias.

Recruitment bias (or identification bias) is the bias that occurs in cluster-RCTs if the personnel recruiting participants know individuals' allocation, even when the allocation of clusters has been concealed appropriately. The knowledge of the allocation of clusters may lead to bias because the individuals' recruitment in cluster trials is o en behind the clusters' allocation to di erent interventions; and the knowledge of allocation can determine whether individuals are recruited selectively.This bias can be judged through considering the following questions.• Were all the individual participants identified/recruited before randomisation of clusters?• Is it likely that selection of participants was a ected by knowledge of the intervention? Cochrane Database of Systematic Reviews• Were there baseline imbalances that suggest di erential identification or recruitment of individual participants between arms?

Baseline imbalance between intervention groups can occur due to chance, problems with randomisation, or identification/recruitment bias. The issue of recruitment bias has been considered above.In terms of study design, the risk of chance baseline imbalance can be reduced by the use of stratified or pair-matched randomisation. Minimisation -an equivalent technique to randomisation -can be used to achieve better balance in cluster characteristics between intervention groups if there is a small number of clusters.Concern about the influence of baseline imbalance can be reduced if studies report the baseline comparability of clusters, or statistical adjustment for baseline characteristics.

Similar to missing outcome data in individually randomised trials, bias can occur if clusters are completely lost from a cluster-RCT, and are omitted from the analysis.The amount of missing data, the reasons for missingness and the way of analysing data given the missingness should be considered in assessing the possibility of bias.

Data analyses, which do not take the clustering into account, in cluster-RCTs will be incorrect. Such analyses lead to a 'unit of analysis error' and over-precise results (overly small standard error) and overly small P values. Though these analyses will not result in biased estimates of e ect, they (if not correctly adjusted) will lead to too much weight allocated to cluster trials in a meta-analysis.Note that the issue of analysis may not lead to concern any more and will not be considered substantial if approximate methods are used by review authors to address clustering in data analysis.

In the case that a meta-analysis includes, for example, both cluster-randomised and individually randomised trials, potential di erences in the intervention e ects between di erent trial designs should be considered. This is because the 'contamination' of intervention e ects may occur in cluster-RCTs, which would lead to underestimates of e ect. The contamination could be known as a 'herd e ect'; that is, within clusters, individuals' compliance with using an intervention may be enhanced, which in return a ects the estimation of e ect. Nicky Cullum: conceived the review; designed the review; checked quality of data extraction; analysed or interpreted data; contributed to writing or editing the review; advised on the review; secured funding; performed previous work that was the foundation of the current review; approved the final review prior to publication.

Sarah Rhodes: conceived the review; designed the review; checked quality of data extraction; checked quality assessment; checked quality of statistical analysis; contributed to writing or editing the review; advised on the review; approved the final review prior to publication.Elizabeth McInnes: conceived the review; designed the review; coordinated the review; checked quality of data extraction; checked quality assessment; contributed to writing or editing the review; advised on the review; performed previous work that was the foundation of the current review; approved the final review prior to publication.

Gill Norman (Editor): edited the protocol; advised on methodology, interpretation and content; approved the final protocol prior to publication.Gill Rizzello (Managing Editor): coordinated the editorial process; advised on content; edited the protocol and the review.Sophie Bishop (Information Specialist): designed the search strategy and edited the search methods section.Tom Patterson (Editorial Assistant): edited the reference sections of the protocol and the review. My previous and current employers received research grant funding from the NHS Research and Development programme and subsequently the NIHR for previous versions of this review. The funders had no role in the conduct of the review. My previous employer received research grant funding from the NIHR for an RCT comparing di erent alternating pressure air surfaces for pressure ulcer prevention. This RCT (for which I was the Chief Investigator) was not eligible for inclusion in this review.

Sarah Rhodes: my salary is funded from three NIHR grants and a grant from Greater Manchester Cancer.Elizabeth McInnes: none known.